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Effects of phorbol myristate acetate (PMA), dibutyryl cyclic
AMP (dbcAMP), 6-dimethylaminopurine (6-DMAP), okadaic acid
(OA), cycloheximide (CHX), actinomycin D (AcD) and tunicamycin
(TuM) on plasminogen activator (PA) activity and maturation rate
in bovine and porcine oocyte-cumulus cell complexes (BOCC and
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activator activity was measured by SDS-PAGE, casein-agar
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were observed in BOCC.Immunoprecipitation and amiloride
sensitivity suggested that the 49-51 kD protease is a urokinase
type PA (uPA), the 71-73 and 92-95 kD proteases are a tissue
type PA (tPA) and tPA-PAI complex, respectively, and the PAI is
PAI-1.In POCC, two plasminogen activators (71-78 and 93-96 KD)
were observed.Lack of amiloride sensitivity suggested that the 71
-78 kD band is a tPA and the 93-96 kD band is possiblya tPA-PAI
complex.Increasing dbcAMP in the culture medium increased
activity in both BOCC and POCC in dose-dependent fashion (P<0.05).
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INTRODUCTION
The plasminogen activator (PA) system is an important source
of extracellular proteolysis accompanying cell migration and
tissue remodelling (Dano et al., 1985; Mullins and Rohrlish, 1983).
Two principal PA have been identified, tissue-type PA (tPA) and
urokinase-type PA (uPA), and their activities are modulated
physiologically by several different inhibitors including PA
inhibitors-1(PAI-1), -2 (PAI-2) and -3 (PAI-3) (Dano et al.,
1985; Kruithof, 1988).Meiotic maturation of oocytes is
associated with increased levels of tPA activity.In rodents,
granulosa and cumulus cells secrete both tPA and uPA, however
oocytes denuded of cumulus cells produce only tPA during
spontaneous in vitro maturation (Huarte et al., 1985; Liu et al.,
1986).Ny et al.(1987) have suggested that GnRH treatment
increases PA activity inrat oocyte-cumulus cell complexes
through the protein kinase C pathway.Conversely, FSH appears to
mediate its effects through the protein kinase A pathway
(Salustri et al. 1985).Although PA activity is increased in rat
oocyte-cumulus cell complexes by stimulators of the protein
kinase A and C systems, it has not been determined if oocyte-
cumulus cell complexes from cattle and pigs produce PA and
whether activity can be regulated by second messenger systems.2
Cycles of cellular phosphorylation and dephosphorylation have
important roles in maturation or M-phase promoting factor (MPF)
activity involved incell cycle control and oocyte maturation
(Draetta and Beach, 1988; Moor and Crosby, 1986).Inhibition of
protein phosphorylation by 6-dimethylaminopurine (6-DMAP)
(Meijer and Pondaven, 1988; Neant and Guerrier, 1988) inhibits
germinal vesicle breakdown (GVBD) in mouse (Rime et al., 1989)
and bovine oocytes (Fulka et al., 1991).Okadaic acid (OA), a
potent inhibitor of phosphatases 1 and 2A (Bialojan and Takai,
1988), induces meiotic maturation and MPF activity when
microinjected into Xenopus and mouse oocytes (Jessus et
al.,1991; Gavin et al., 1991).Okadaic acid is also a potent
inducer of the uPA gene through a mechanism independent of the
protein kinase
Despite this information,littleis known about the role of protein
phosphorylation on PA activity in bovine and porcine oocytes
matured in vitro.The regulatory mechanisms involved in meiotic
maturation are quite different among species.In rodents GVBD
occurs independently of protein synthesis (Schultz and
Wassarman, 1977; Clarke and Masui, 1983), however both protein
and mRNA synthesis are required for GVBD in cattle (Hunter and
Moor, 1987; Sirard et al., 1989).Little is known about the role of
mRNA and protein synthesis in PA activity in bovine and porcine
oocytes matured in vitro.
Therefore the objectives of these studies were to 1)
characterize the type of PA and PAI produced by bovine and3
porcine oocyte-cumulus cell complexes (BOCC and POCC,
respectively) 2) investigate the effects of dbcAMP, PMA, 6-DMAP
and OA on PA activity and maturation rate in BOCC and POCC , and
3) investigate the effects of cycloheximide, actinomycin D and
tunicamycin on PA activity and maturation rate in BOCC matured
invitro.4
REVIEW OF LITERATURE
I.Meiotic Maturation of the Oocyte
Oogonia are mitotic cells of the germ line and are located in
the primitive ovary.In response to an unknown signal, oogonia
enter meiosis and become oocytes. In most mammals, the
progression of meiosis in oocytes is initiated near the time of
birth when oogonia cease proliferating and enter prophaseIof
meiosis.DNA synthesis and a number of cytoplasmic changes
occur at this time during the transition from oogonium to primary
oocyte.Primary oocytes are distinguished by a large nucleus,
termed the germinal vesicle, containing decondensed chromatin.
Oocytes then progress through the first meiotic prophase.
Several reviews (Baker, 1982; Eppig, 1992; Schultz, 1992) have
summarized the chromosomal morphology during this period.
Meiotic prophaseIis divided into five substages: leptotene,
zygotene, pachytene and diplotene and diakinesis.During
leptotene, chromosomal condensation occurs, and synaptonemal
complexes consisting of two outer threads of chromosomal
material separated by a fine association line are formed in
zygotene.Pachytene, which is the stage of completion of
synaptonemal complex formation,is characterized by genetic
crossing over and recombination between chromatids.Oocytes
then enter diplotene when loss of the synaptonemal complexes
Occurs.The prolonged diplotene stage in oocytes is referred to
as the dictyate stage.Oocyte growth is generally correlated
with granulosa cell proliferation.As the oocyte grows, the5
number of layers of granulosa cells around the oocyte also
increases.Anderson and Albertini (1976) and Gilula et al. (1978)
reported that granulosa cells are involved in oocyte growth and
gap junction development at points of apposition between the
granulosa cell and oocyte plasma membranes.Gap junctions are
membrane specializations that allow low molecular weight
molecules to diffuse directly from one cell to another.These
molecules can participate in the metabolism and regulation of
oocyte development (Gilula et al., 1978).
The preovulatory surge in gonadotropins signals the release
from arrest, and oocytes complete meiosis by undergoing two
successive nuclear divisions.The nuclear membrane dissolves
and commences germinal vesicle breakdown and chromosomes
progress from prophase I thru metaphase I and anaphase Ito
telophaseI.The completion of the first meiotic division is
characterized by the extrusion of the first polar body.Shortly
after the extrusion of the first polar bodythe secondary oocyte
starts the second meiotic division.Spindle microtubules
subsequently appear adjacent to the chromatin and the
chromosomes arrange themselves on the metaphase plate.
Metaphase IIis a stage of arrest in the majority of species, and
ovulation occurs at this stage.
It has been known for many years that oocytes present within
an explanted preovulatory antral follicle do not resume meiosis,
but do so in response to added gonadotropin or removal of the
oocyte from the follicle (Pincus and Enzmann, 1935).A
reasonable interpretation of these resultsisthat the follicle6
exerts an inhibitory effect on oocyte maturation.Cyclic
adenosine 5'-monophosphate (cAMP), which is present in the
oocyte, is the most likely candidate for maintenance of meiotic
arrest based on the observation that membrane-permeable cAMP
analogs inhibit oocyte maturation in vitro (Cho et al. 1974;
Racowsky, 1986; Bornslaeger et al, 1986a).In addition
phosphodiesterase inhibitors, which prevent degradation of
intracellular cAMP, reversibly suppress GVBD in vitro (Eppig and
Downs, 1988).Bornslaeger et al. (1986a) suggested that an
inhibitory basal level of cAMP is present in the oocyte and this
cAMP activates protein kinase A (PKA) which is a heterotetramer
composed of two regulatory subunits and two catalytic subunits.
Binding of cAMP to the regulatory subunits promotes the
dissociation of the catalytic subunits, which are now active.
The activated PKA phosphorylates an unknown protein, termed
protein X, which is necessary for germinal vesicle breakdown
(GVBD), and this results in maintenance of meiotic arrest.
Resumption of meiosis is triggered by a decrease in the
inhibitory levels of oocyte cAMP resulting in reassociation of
active catalytic PKA subunits with regulatory subunits, and hence
a decrease in PKA activity.A protein phosphatase is then
speculated to convert inactive phosphorylated protein X to active
dephosphorylated protein X, which is involved in resumption of
meiosis.
Dekel and Beers (1980) have postulated a model for the
mechanism of gonadotropin-induced meiotic resumption.The
cAMP that is necessary to maintain meiotic arrest is derived7
from the surrounding folliclecells, which possess an active
adenylate cyclase, and enters the oocyte cytoplasm via gap
junctions.This transfer of cAMP from follicle cells to the
oocyte inhibits resumption of meiosis of follicle-enclosed
oocytes.Gonadotropins induce resumption of meiosis by
terminating gap junction-mediatedintercellular communication
between the cumulus cell and the oocyte.Without exogenous
sources of cAMP, the oocyte is no longer able to maintain an
inhibitorylevel of cAMP.The oocyte can not generate its own
cAMP and the oocyte's phosphodiesterase activity induces a cAMP
decrease that results in resumption of meiosis (Dekel and Beers,
1980).There is also indirect evidence that cAMP made in
follicle cells can be transmitted to the oocyte.Oocytes obtained
from cumulus cell-oocyte complexes treated with either follicle
stimulating hormone (FSH) or cholera toxin contain more cAMP
than denuded oocytes that are similarly treated (Bornslaeger and
Schultz, 1985; Racowsky, 1984; Salustri et al.,1985).
Bornslaeger and Schultz (1985) suggested that resumption of
meiosis in vitro may be due to termination of follicle cell cAMP
transfer to the oocytes.Gonadotropin-induced resumption of
meiosis results in a rapid down-regulation of the number of
homologous gap junction between cumulus cells and oocyte that
correlates with GVBD in rat oocytes (Larsen et al., 1986).This
reduction in the extent of communication between the cummulus
cells and oocyte would efficiently isolate oocyte from the
folliclecells.8
The effects of protein kinase C (PKC), which is the calcium,
phospholipid-dependent protein kinase activated by
diacylglycerol or phorbol diesters, on oocyte maturation have
been examined.Biologically active phorbol diesters inhibit GVBD
in the mouse oocyte in a dose-dependent manner (Bornslaeger et
al, 1986b).Retinoic acid, which is knownto reverse the effects
of phorbol diesters, overcomes the inhibitory effect of phorbol
diesters on mouse oocyte maturation (Urner, 1984).Bornslaeger
et al. (1986b) suggest the mechanism of these agents, which
inhibit oocyte maturation, differ from that of cAMP.Elevation of
oocyte cAMP levels after GVBD does not inhibit polar body
emission, whereas addition of PKC activators after GVBD does
inhibit polar body emission.Although the PKC activators do not
inhibit the apparent dephosphorylation, their ability toinhibit
GVBD correlates with inhibition of the apparent increase in
phosphorylation.In addition,in contrast to the inhibitory effect
of PKC activators on mammalian oocyte maturation, PKC
activators induce maturation in Xenopus and Spisula oocytes
(Stith and Ma Iler, 1987;Eckholan et al.,1987).
Goren et al. (1990) reported that treatment of oocytes with
calcium ionophore, A 23187, or increasing extracellular calcium,
stimulated maturationin follicle-enclosed oocytes.In addition,
LH stimulation of follicle-enclosedrat oocyte maturation was
dependent upon external calcium concentration.Intracellular
chelaters of calcium or inhibitors of calcium uptake have also
been shown to prevent spontaneous maturation ( Goren et al.,
1990; Homa, 1991; De Felici et al., 1991).The release of calcium9
from intracellular stores within the oocyte may positively
influence the meiotic response (Homa et al., 1991).However,
Flores et al. (1992) reported that FSH stimulated increase in
intracellular calcium inisolated granulosa cells.This result
suggests that calcium released by follicle cells in response to
gonadotropin stimulation could flow down a concentration
gradient, through the gap junctions, and into the oocyte to induce
GVBD.
Purines such as hypoxanthine and adenosine have been also
shown to inhibit oocyte maturation at concentrations present in
follicular fluid.Hypoxanthine and adenosine have been shown to
act synergistically to maintain meiotic arrest (Eppig et al.,
1983).Eppig et al. (1983) hypothesized that the synergism of
hypoxanthine and adenosine is due to suppression of
phosphodiesterase by hypoxanthine combined with stimulation of
cAMP production by adenosine.Purine-induced inhibition of
GVBD is markedly enhanced when either dibutyryl cAMP (dbcAMP)
or the phosphodiesterase inhibitor, isomethylxanthine (IBMX) is
present at concentrations that by themselves do not result in
significant inhibition of GVBD (Downs and Eppig, 1987).Thus,
purines would potentiate dbcAMP-mediated inhibition of GVBD by
raising the effective intracellular concentration of the cAMP
analog or augment IBMX-induced inhibition of GVBD by further
inhibiting endogenous phosphodiesterase activity (Downs et al.
1989).Steroid hormones such as progesterone, testosterone and
17 13-estradiol can inhibit GVBD in denudedmouse oocytes (Kaji10
et al., 1987).These steroid hormones can also potentiate the
maturation inhibition of denuded oocytes by low concentrations
of dbcAMP (Eppig et al., 1983; Rice and McGaughey, 1981).Kaji
etal. (1987) reported that the likely basis for this synergistic
inhibition with dbcAMP is that steroid hormones inhibit oocyte
phosphodiesterase activity.The activity of steroid hormones to
inhibit oocyte phosphodiesterase thus accounts for their ability
to potentiate inhibition of GVBD by low concentrations of
dbcAMP.
A number of changes in the pattern of protein synthesisoccur
subsequent to GVBD, and these may be necessary for continued
nuclear progression (Schultz and Wassarman, 1977; Schultz et al.,
1979).However, addition of protein synthesis inhibitors shortly
after GVBD permits the oocytes to emit a polar body and arrest
at metaphase II(Schultz et al., 1979).In rodents, GVBD occurs
when protein synthesis is inhibited (Eckholm and Magnusson,
1979; Wassarman et al., 1976), however protein synthesis is
required for GVBD in porcine and ovine oocytes (Fulka et al.,
1986; Moor and Crosby, 1986).A possible explanation for these
species differences is that in rodents, GVBD starts tooccur
within 45 to 60 min following oocyte isolation, whereas in large
animals, GVBD takes several hours following oocyte isolation
(reviewed by Schultz, 1992).
There are several reports indicating that granulosa cells
(Tsafriri and Channing, 1975), follicular fluid (Chang, 1955;
Tsafriri et al.,1977) and granulosa cell-conditioned medium
(Tsafriri et al., 1976) contain a substance(s) thatcan inhibit11
GVBD in oocytes.This led to the idea that an oocyte maturation
inhibitor (OMI) exits that is produced by somatic cells of the
follicle, and causes maintenance of meiotic arrestin oocytes
(reviewed by Leibfried-Rutledge et al., 1989).Oocyte maturation
inhibitor, which is proposed to be a low molecular weight
polypeptide, has been partially purified using a bioassay that
quantifies the effect of follicular fluid and purified fractions on
their ability to inhibit GVBD.The source of OMI has been shown
to be the granulosa cells.Germinal vesicle breakdown can be
suppressed when oocytes are cultured with granulosa cells or
follicle walls (Tsafriri et al.,1975).Inhibition of GVBD was
also observed if culture medium was conditioned by granulosa
cells or contained extracts of granulosa cells (Anderson et al.,
1985).The inhibitory activity separates into several components
during purification, and thusitisnot clearifmultiple inhibitors
that are chemically distinct are present or whether these
differences reflect multiple forms of the same molecule. Also
conflicting results are obtained following protease treatment of
these partiallypurified fractions; sometimes the inhibitory
activityislost and sometimes itis not.
Mullerian inhibiting substance (MIS), which is related to
transforming growth factor-13 (TGF-(3), is responsible for
regression of the Mullerian duct.Takahashi et al (1986) reported
that MIS is present in the ovary throughout fetal and adult life
and is present in granulosa cells and follicular fluid.They
observed that MIS inhibited GVBD in either denudedor cumulus12
cell enclosed rat oocytes, and antibodies to MIS overcame MIS
inhibition of GVBD.In contrast, results of another study
immunopurified MIS could not demonstrate any inhibition of GVBD
in cumulus cell-enclosed rat oocytes (Tsafriri et al.,1988).
Although MIS may play a regulatory role in maintenance of
meiotic arrest, further experimentationis obviously required to
strengthen this proposal.
Maturation or M-phase promoting factor (MPF) which was first
described in amphibian oocytes, controls the transition from G2
to M phase in both meiosis and mitosis (Masui and Market, 1971).
Maturation promoting factor has recently been purified from
Xenopus eggs, and one of its subunits has been identified as the
frog homolog of the schizosaccaromyces prombe cdc protein
(Dunphy et al., 1988; Gautier et al., 1988).Dunphy and Newport
(1989) reported that the Xenopus cdc2 component of MPF is
tyrosine phosphorylated in vivo, and this tyrosine phosphorylation
oscillates with the cell cycle.Gautier et al. (1990) recently
reported that highly purified MPF from Xenopus eggs contains
cyclin.Cyclin synthesis is necessary for entry into mitosis and
the destruction of cyclinis required for exit from mitosis
(Murrary, 1989).Collectively mitosis and meiotic maturation
are induced by the activation of MPF, a protein kinase whose
principal subunits are the cdc protein, which has extensive
homology to known protein kinases, and cyclin, a regulatory
subunit whose abundunce fluctuates through the cell cycle
(reviewed by Glotzer et al., 1991).13
II.Plasminogen Activator
Biochemical Aspects
Plasminogen activators (PA) are serine proteases that
convert the zymogen plasminogen to the serine protease plasmin.
Plasminogen can be purified bya combination of affinity
chromatography binding to agarose L-lysine columns and ion-
exchange chromatography on carboxymethyl-cellulose or
diethylamineethyl-sephadex.Human plasminogen has a
molecular massof 83-92 kD and is composed of a single chain
glycoprotein consisting of 790 amino acids with a glutamic acid
residue at the amino-terminus and an asparagine residue at the
carboxy-terminus.Two major forms of plasminogen have been
identified: Glu-plasminogen which has glutamic acid at the amino
terminus, and Lys-plasminogen which has lysine at the amino
terminus (Christman et al., 1977). Plasminogen activator can
convert either Glu-plasminogen or Lys-plasminogen to Glu
-plasmin or Lys-plasmin by cleavage of the Arg 560-Val 561
bond.Plasmin is a two chain molecule in which the polypeptide
chains are held together by two disulfide bonds.The heavy (A)
chain has a molecular mass of 48-68 kD and contains
carbohydrate units as well as the lysine binding sites.The light
(B) chain has a molecular mass of 20-25 kD and contains the
serine protease portion of the molecule.
Plasminogen and plasmin have a high degree of homology
among the different mammalian species in regard to terminal
amino acid sequences and molecular mass (Robbins et al., 1973;
Summaria et al., 1973; Christman et al., 1977).Summaria et al.14
(1973) reported that the molecular masses and amino acid
sequences of plasminogen from cat, dog, rabbit and bovine were
similar with the human.The heavy (A) chain of plasmin is
charaterized by five triple loop structures known as kringles.
Kringle domains are also present in prothrombin, urokinase, and
several other fibrinolytic proteases.Recent research suggested
that kringles mediate the attachment of plasminogen or plasmin
to the fibrin matrix of blood clots (Petros et al., 1988; Thewes et
al., 1988).Receptors for plasminogen and plasmin have been
identified in human tumor cell line SW 1116 (Burtin and
Foundameche, 1988).These receptors are the same for both
plasminogen and plasmin, but exhibit much higher affinity for
plasmin.Plasmin bound to the receptor retains its enzymatic
activity, and may activate prourokinase resulting in the
formation of urokinase, which in turn increases plasmin.
Ultimately, this process increases the concentration of plasmin
at the surface of tumor cells, enabling them to degrade the
component proteins in connective tissues and basement
membranes.Plasma contains several protease inhibitors which
regulate the fibrinolytic system.a2-antiplasmin and a2
-macroglobulin are the most important inhibitorof plasmin.a2
antiplasminis characterized by rapid inactivation of plasmin,
while a2-macroglobulin exerts its action only when a2
antiplasmin levels are depleted (Dann et al., 1985).The
reactive site of a2-antiplasmin bind to the active site of
plasmin, resultingin a covalent complex which is enzymatically15
inactive.
Two major plasminogen activators have been identified by
functional differences and by immunological reactivites:
urokinase-type PA (uPA) and tissue-type (tPA). Urokinase-type
PA exhibits a molecular mass between 30 and 55 kD, whereas tPA
is approximately 72 kD (Dano et al., 1985).Both uPA and tPA are
secreted as single-chain polypeptides (scuPA and sctPA). Inits
single-chain form, they are proenzymes withlittleor no activity
(Eaton and Baker, 1984; Pannel and Gurewich, 1987).According
to Pannell and Gurewich (1987), the enzyme activitiesof the
single-chain form appear to be only 0.2-0.4% of the respective
activities of the active enzymes.Lijnen et al. (1986) reported on
the activity of scuPA.When scuPA and plasminogen were
combined, two-chain uPA and plasmin were formed.Addition of
plasmin inhibitors to this mixture abolishes the generation of
uPA but not the activation of plasminogen to plasmin, suggesting
that scuPA can activate plasminogen directly.ScuPA is activated
to uPA by cleavage of a peptide bond, which results in the
formation of the two chain form of uPA.This process takes
place in the extracellular spaces and can be mediated by plasmin
(Dano et al., 1985).Urokinase-type PA was originally isolated
from human urine but has since been found in human plasmaand in
conditioned media of several types of cell lines (Danoet al.,
1985).Urokinase-type PA is a glycoprotein that is synthesized
as an one-chain proenzyme (55kD) and is converted to the active
enzyme by a proteolytic cleavage yielding a disulfide-linked two
-chain molecule.Gunzler et al. (1982) reported the complete16
amino acid sequence of uPA from human urine.The high
molecular mass form of uPA consists of a catalytic subunit (B
-chain; 33 kD)and a non-catalytic subunit (A-chain; 25 kD).The
B-chain is homologous to the catalytic subunit of other serine
proteases.The A-chain or light chain contains one kringle
domain and a domain required for interaction with a cellular
receptor (Dano et al., 1985; Hart and Rehemtulla, 1988; Vassali et
al., 1985).
Tissue-type PA is a serine protease also synthesized as a
proenzyme and composed of 530 amino acids (Degen et al., 1986).
Limited proteolysis by plasmin, kallikrein, or factor Xa cleaves
the Arg-Ile bond of the proenzyme yielding two polypeptide
chains linked by a disulfide bond.The catalytic site of tPA is
located in the light chain (B-chain), which has a molecular mass
of 30 kD, and iscomposed of His-322, Asp-371 and Ser-478
residues (Degen et al., 1986).The heavy chain (A-chain) consists
of several structural domains and shares a high degree of
homology with other hemostatic proteins.These domains are
categorized as the fibronectin finger domain, the epidermal
growth factor domain, and the two kringle domains (I and II)
(Gerard et al., 1986).Van Zonneveld et al. (1986) reported that
deletion of the kringleII domain reduced the activation of the
enzyme by fibrin while deletion of both the finger and kringle
domains abolished the fibrin-induced alterationin enzyme
activity. Therefore, the finger and kringle domains are
responsible for the interaction of tPA with fibrin.Tissue type
plasminogen activator is a glycoprotein with approximately 7%17
carbohydrate (Ranby et al., 1982).Little et al. (1984) reported
that this carbohydrate does not likely influence the activity of
the enzyme because removal of the carbohydrate by glycosidase
did not alter enzyme activity.However they found that the
enzyme was not secreted from a tissue culture cell line when
cultured with the glycosylationinhibitor, tunicamycin.
Therefore, glycosylation of the enzyme is required for transport
of the protein out of cell.
Regulation of proteolysis is important for the maintenance of
homeostasis, and is maintained in part by specific PA inhibitors.
At least four inhibitors of PA have been identified: PA inhibitor-1
(PAI-1); PA inhibitor-2 (PAI-2); PA inhibitor-3 (PAI-3), and
protease nexin.Plasminogen activator inhibitor-1is the major
PAI in plasma and is believed to be involved in the regulation of
plasma tPA activity (Gerard et al., 1986; Kruithof et al., 1986).
The primary structure of human PAI-1 has been determined by
nucleotide sequencing of cloned cDNA and by amino acid
sequencing (Andreasen et al., 1986; Ginsburg et al., 1986; Wun and
Kretzmer, 1987). Plasminogen activator inhibitor-1 can form
an SDS-stable complex with tPA yielding a proteinase-inhibitor
complex of 110 kD (Kruithof et al., 1984; Thorsen and Philips,
1984; Wagner and Binder, 1986).Synthesis of PAI-1is regulated
by many of the same effectors that regulate the expression of PA.
Itis interesting that factors causing an increase in the
expression of PA often also increase the secretion of the
inhibitor (Saksela and Rifkin, 1988).
Plasminogen activator inhibitor-2 has been purified and18
characterized from several tissues including placenta,
monocytes, leukocytes and fibrosarcoma cells (Kruithof, 1988).
Plasminogen activator inhibitor-2 existsintwo different forms:
a 47 kD, nonglycosylated form and a 60 kD, glycosylated form.
The cDNA of PAI-2 has been cloned, and the amino acidsequence
deduced from this cDNA confirms that this PAI belongs to the
serpin serine protease inhibitor family.Plasminogen activator
inhibitor-2 also can form SDS-stable complexes with PA yielding
PA-inhibitor complexes detectable by zymography, and is thought
to play a role in the regulation of extracellular PA activity
involved in tissue remodelling.
Plasminogen activator inhibitor-3 has been purified and
characterized from human urine and plasma (Stump et al., 1986).
Itis also a glycoprotein with a molecular mass of 50 kD, and
forms complexes mainly with uPA.The physiological role of the
human PAI-3 is unknown.Protease nexin is distinct from PAI 1
-3 in thatitis not specific for PA.It can bind to and is
activated by heparin and plasmin (Sprenger and Kluft, 1987).
Protease nexin is also a glycoprotein (47 kD).
Functional Aspect
Plasminogen activators mediate the specific conversion of
plasminogen into plasmin, a proteolytic enzyme of broad
substrate specificity.The primary function of tPA is
intravascular thrombolysis, whereas uPA is thought to be
involved in the generation of proteolysis during cell migration
and tissue remodelling (Dano et al., 1985; Saksela and Rifkin,
1988)The distribution of PA in reproductiveorgans is well19
-documented and many studies have been conducted to investigate
the role of PA in male and female reproduction.
Ovulation in mammals is a unique phenomenon involving both
oocyte maturation and rupture of the follicle wall to release the
egg.Plasminogen activators have been detected in large
quantities during the ovulatory process indicating a close
correlation between ovulation and PA.Beers et al. (1975)
demonstrated increases in PA activities ofin preovulatory
follicles and proposed a causal relationship between PA
increases and follicle rupture. Plasminogen, PA and PAI have been
also detected in large amounts in the follicular fluid.The
activation of follicular plasminogen to plasmin by PA decreases
the tensile strength of the follicle wall (Beers, 1975). Beers et
al. (1975) proposed that granulosa cells elaborate increasing
amounts of PA in response to the increased levels of circulating
LH.This enzyme acts on follicular plasminogen generating
plasmin within the follicle wall.Plasmin, inturn, activates
another protease, collagenase, which allows further degradation
of collagen in the follicle wall.
Gonadotropins stimulate the release of PA from inactive
ovarian granulosa cells in a time and dose-dependent fashion
(Beers et al., 1975).Strickland and Beers (1976) reported that
FSH was more effective in inducing PA activity than LH,and
prostaglandin and cAMP stimulate the production of PA by
granulosa cells.Both uPA and tPA have been demonstrated in
granulosa cells.Liu et al. (1987) studied the activity of tPA and
uPA in granulosa and theca-interstitial cells obtained from20
gonadotropin-treated immature rats during the periovulatory
period.They showed that tPA activity in both granulosa and
theca-interstitialcells increased after pregnant mare'sserum
gonadotropin (PMSG) and human chorionic gonadotropin
treatments and reached a maximum prior to ovulation.Liu and
Hsueh (1987) also studied the molecular patterns and secretion
of PA in rat cumulus-oocyte complexes.Both tPA and uPA were
present in the cumulus-oocyte complexes, while denuded oocytes
contained only tPA.Human chorionic gonadotropin (hCG)
treatment induced a time dependent increase in tPA activityin
both cumulus-oocyte complexes and denuded oocytes.
Morphological signs of cumulus cell expansion and dispersionwas
observed after increases in oocyte tPA activity.
Tsafriri et al. (1989) examined the relationship between PA
and ovulation using a2-antiplasmin andan anti-tPA.They
reported that anti-tPA and a2-antiplasmininhibitedovulation
only when injected at the time of hCG treatment.Species
differences were reported with regard to the types of PA
secreted by granulosa cells.Rat granulosa cells secrete mainly
tPA, while mouse cells secrete predominantly uPA (Canipariet
al., 1987).Smokovitis et al. (1988) reported that the follicle
wall and follicular fluid from sows have both tPA anduPA, and
activities are greatest at ovulation.Ny et al. (1987) studied the
effect of GnRH on tPA activity in rat granulosa cellsand cumulus
-oocyte complexes.Gonadotropin-releasing hormone increased
the level of tPA activity in granulosa cells.Gonadotropin21
-releasing hormone also increased tPA content in oocytes through
a mechanism mediated by the adjacent granulosa cells.It has
been suggested that GnRH may act on cumulus cells to increase
unidentified messenger molecules which then may be transported
to the oocyte via gap junctions to signal an increase in tPA level.
Primary oocytes do not contain detectable amounts of tPA, butit
is induced duringmeiotic maturation of the cell.Huarte et al.
(1985) reported primary oocytes contain tPA mRNA, and its
translationis triggered during the process of meiotic maturation.
The induction of tPA activity in the oocytes is inhibited by
cycloheximide suggesting that tPA mRNA is under translational
control.The role of PA in the oocyte is unknown.It may prevent
trapping of the released oocyte in the fibrin deposits observed in
the oviduct during and after ovulation since most ofitis
secreted before or during fertilization.
Involution of the mammary glands is charaterized by
considerable tissue degradation and remodeling.Ossowski et al.
(1979) reported a strong correlation between mammary gland
involution and the amount of uPA in mice.Only uPA was
identified in extracts from involuting mammary gland.The
importance of PA during involution of the mammary glands is
believed to be necessary for preparing the udder for the next
lactation (reviewed by Dano et al., 1985).
Sertoli cells are found along the basement membrane of the
seminiferous tubules.Sertoli cells have been shown to secrete
several proteins including PA in response to hormonal
stimulation (Fritz et al., 1976; Lacroix et al., 1979).Lacroix et22
al. (1981) observed PA activity inrat testis tubule segments at
different stages of the cycle of the seminiferous epithelium.
Plasminogen activators were observed to increase 100-fold at
stages VII and VIII of the cycle.Stages VII and VIII of the cycle
include the events of spermiation occurs and movement of Sertoli
cell cytoplasmic processes around leptotene spermatocytes.
Lacroix et al. (1981) concluded that PA is involved in the
localized restructuring of the seminiferous epithelium during
translocation of spermatocytes inmeiosis into the adluminal
compartment.Nettle et al, (1986) examined the type of PA
synthesized and secreted by cultured rat Sertoli cells and
seminiferous tubules.They observed that Sertoli cells
maintained under basal conditions secreted uPA.In contrast,
Sertoli cells cultured in FSH or dbcAMP produced mainly tPA.
Immunohistochemical studies showed the presence of uPA
exclusively at stages VII and VIII in Sertoli cells,On the other
hand, tPA immunoreactivity was maximal during stage IX-XII
(Vihko et al., 1988).These results suggest that PA secreted
from Sertoli cells at stages VII and VIII facilitates the release
of preleptotene spermatocytes and movement of cytoplasmic
extensions allowing for maintenance of the tight junctional
complexes in the basal region of the tubule.
Liedholm and Astedt (1975) provided the first report of the role
of PA in the rat embryo.They demonstrated that PA activity of
fertilized rat ova was high during tubal passage on days 1-4 but
this activity decreased on day 5 and disappeared at implantation.
Liedholm and Astedt (1975) suggested that the low PA activity23
during implantation may be required for embryo attachment to
the endometrium.Strickland et al. (1976) examined the
production of PA during the early periods of mouse embryo
development.Plasminogen activators were produced by cultured
blastocysts in a complex pattern.In the first phase, PA activity
increased to day 6 and reached a maximum at day 8 or 9, then
decreased.In the second period, PA activity increased at day 11
and reached a peak at day 15, at which point the enzyme activity
was 5-fold higher than on day 8.
Bode and Dziadek (1979) studied PA production in both
embryonic and extraembryonic mouse tissues.Their results
demonstrated that PA secretion was initiated progressively in
different mouse embryo tissues during development from the 7th
to 10th day of gestation.By day 10 of gestation, all tissues
which were tested (parietal endoderm, sac endoderm, mesoderm,
and amnion) secreted PA.They concluded that although PA may
appear at different stages of development, the presence of this
enzyme in various parts of the midgestation embryo indicates an
important function in embryo growth.Sherman (1980) evaluated
PA activity in empty zonae pellucidae and mouse embryos.He
reported that PA activity was restricted to the zona pellucida,
and that this enzyme was not involved in hatching from the zona
pellucida.Because blastocysts produce PA at the same time
trophoblast cells acquire their migratory properties, Sherman
(1980) concluded that PA plays a pivotal role in trophoblast
invasiveness during implantation.Mullins et al. (1980) examined
whether the absence of invasive implantation within the porcine24
uterus was due to a failure of the conceptus to produce PA or the
presence of an inhibitor.Plasminogen activator activityin
uterine flushings was high during the early and late stages of the
estrous cycle.In contrast, the activity of the enzyme became
low on day 12 of gestation.A time-dependent increase in PA
activity was observed in conditioned medium from blastocysts,
indicating that enzyme activity was inhibitedinvivo.
Plasminogen has been detected in uterine flushings from both the
pig and mouse (Fazleabas et al., 1983; Finlay et al., 1983).
Menino and O'Claray (1986) compared the development of mouse
embryos in media supplemented with plasmin, plasminogen,
trypsin or pronase.More embryos developed to blastocysts and
hatched in medium with plasmin or plasminogen.Also,
incidences of attachment to the substratum and trophoblastic
growth were greater in the presence of plasmin and plasminogen.
In our laboratory, several studies have been designed to
charaterize PA production and to elucidate the function of this
enzyme in early embryos from different species.Menino and
Williams (1987) evaluated plasminogen activation by cultured
bovine embryos.Plasminogen activator production was low for
the first 48 h of culture, increased between 48-120 h and
plateaued thereafter.They found that plasminogen had no effect
on the hatching rate, but high concentrations of this zymogen
accelerated hatching.Kaaekuahiwi and Menino (1989)
demonstrated that PA activity was positively correlated with the
viability of bovine embryos, suggesting that PA secretionmay be
used an indicator of embryo viability.Dyk and Menino (1991)25
used SDS-PAGE and zymography to determine that day 12-14
bovine blastocysts secreted a light form (49kD) and heavy form
(86kD) of PA.Subsequent results demonstrated that PA activity
in bovine embryos could be completely suppressed by amiloride
and antibodies to human uPA, whereas PA activity was unchanged
with antibodies to human tPA suggesting the heavy form isa uPA
-PAI complex (Berg and Menino, 1992).Menino et al. (1989)
evaluated PA production by ovine embryos and the effects of
plasminogen on ovine embryo development and zona pellucida
integrity.They reported that more blastocysts hatched in
medium containing 60 and 120 mg/ml plasminogen than in
medium containing 0 mg/ml plasminogen.Plasminogen activator
activity was low until the morula stage, increased during the
morula-blastocyst transition and remained high throughout
blastocoelic expansion and hatching.Unlike the cow, increasing
levels of plasminogen in the culture medium increased both the
hatching rate and the solubility of the zona pellucida.
Regulatory aspect
Total PA activity in a tissue is determined by the rate of
biosynthesis, release from producer cells, conversion of
proenzymes to active enzymes, and by the presence of
stimulatory factors and inhibitors of enzyme activity (Dano et
al., 1985).Several hormones, second messenger systems and
other factors have been shown to modulate PA activity either
directly or indirectly by affecting the availability of substrateor
inhibitors.26
Plasminogen activator activity has been found to be increased
by LH, GnRH, FSH and hCG in granulosa cells of rat ovaries(Beers
et al., 1975; Strickland and Beers, 1976; Liu et al., 1981; Nyet
al., 1987) and rat cumulus-oocyte complexes (Liu and Hsueh,
1987, Liu et al., 1987; Ny et al., 1987).Follicle stimulating
hormone also stimulates the activity of PA inrat Sertoli cells
(Lacroix et al., 1977; Lacroix and Fritz, 1982).The generally
accepted hypothesis is that cAMP mediates theresponse to this
hormone.Other compounds known to increase cellular cAMP
levels such as phosphodiesterase inhibitors and cholera toxin
have also been found to affect PA activity (Dano et al., 1985).
The molecular mechanism of PAgene regulation by cAMP is not
established.The gene regulatory effect of cAMP is usually
mediated by cAMP-dependent protein kinase A.The binding of
cAMP to the regulatory subunits results in the release and
subsequent activation of the catalytic subunits.Nigg et al.
(1988) showed subcellular distribution of protein kinaseA by
immunocytochemical analysis, indicating that cAMP regulatesand
induces the transcription of the PA gene.
Gonadotropin-releasing hormone (GnRH) induces the production
of PA mRNA in granulosa cells inthe rat.Ny et al. (1987) have
suggested that GnRH treatment increases PA activityin rat
oocyte-cumulus cell complexes through the protein kinaseC
pathway.Phorbol 12-myristate 13-acetate (PMA),a known
stimulator of protein kinase C has been found to enhancePA
activity (Vassalli et al., 1977; Quigley, 1979).Santell and Levin
(1988) studied the effects of phorbol esters and cAMPon PA and27
PAI secretion.Phorbol esters induced a time- and dose
-dependent increase in PA release from endothelial cells,in
which cAMP had no effect.However cAMP elevation can increase
PAI secretion.Meyer et al. (1988) investigated the effect of
phorbol esters on PA secretion in human rhabdomyosarcoma cells
by using an enzyme-linked immunosorbent assay (ELISA).They
reported that PMA increased the cellular level of PAI-1 mRNA and
PAI-1 gene transcription rate.Opdenakker et al. (1983) reported
that treatment with phorbol ester in human Bowe melanoma cells
enhanced PA production and increased the cellular level of PA
mRNA.This suggests that phorbol esters participate, either
directly or indirectly,in inducing PA gene transcription.
Cycloheximide and actinomycin D have been reported to block
cAMP effects on PA activity (Wilson and Reich, 1977; Granelli
-Piperno and Reich, 1983).However cycloheximide treatment did
not suppress PMA-stimulated increase of PAI-1 mRNA indicating
that protein synthesis was not required for the PMA effect.
Treatment with both cycloheximide and PMA resulted inan
increase in PAI mRNA levels, which indicated thata short-lived
protein negatively regulates the level of PAI-1 mRNA either by
suppressing PAI-1 gene transcription or by destabilizing the
mRNA.
Epidermal growth factor (EGF) enhances PA activity in cultured
human foreskin fibroblasts (Eaton and Baker, 1983).Lee and
Weinstein (1978) reported that EGF causedan increase in both
intracellular and extracellular levels of PA activityin HeLa cells.
Induction of PA activity in these cellswas blocked by28
actinomycin D and cycloheximide, suggesting that EGF induces de
novo synthesis of PA in a manner dependent on the continued
synthesis of mRNA (Dano et al., 1985).
Fibroblast growth factor (FGF) has been reported to increase PA
production in cultured bovine capillary endothelial cells (Gross et
al., 1982) and newborn rat astroglial cells (Rogister et al., 1988).
Incontrast, TGF-f3 inhibited PA activityin capillary endothelial
cells (Saksela et al., 1987), and stimulated production of PAI-1
in human endometrial adenocarcinoma cells (Presta et al., 1988)
and human tumor cell line HT-1080 (Laiho et al., 1987).
Estrogens have been reported to increase uPA activity in the rat
uterus (Katz et al., 1976; Peitz et al., 1983) and in the human
breast carcinoma cell line MCF-7 (Butler et al., 1979).Estrogen
has been shown to induce the production of plasmin-inhibitor by
pig endometrium during the period of implantation, thus
preventing the proteolytic degradation of the uterine wall
(Fazleabas et al., 1983).Glucocorticoids have been reported to
suppress uPA activity in a variety of cultured cells (Dano et al.,
1985).The response of tPA activity to glucocorticoidsappears
to be more variable.Glucocorticoids did not affect tPA activity
in melanoma cell lines (Roblin and Young, 1980) and in cultured
bovine aortic endothelial cells (Granelli-Piperno and Reich,
1983).These steroid hormones are generally believed to
influence protein synthesis by changing the rate ofgene
transcription and translation.The protein synthesis inhibitor
cycloheximide has been shown to block the estrogen induction of29
PA activity in MCF-7 cells (Butler et al., 1979).It has also been
found that RNA synthesis inhibitors such as actinomycin D,a
-amanitin and bromotubercidin inhibit glucocorticoid and
estrogen suppression of intracellular levels of uPA (Wilson et al.,
1983).30
FACTORS AFFECTING PLASMINOGEN ACTIVATOR ACTIVITY
IN BOVINE OOCYTE- CUMULUS CELL COMPLEXES MATURED IN VITRO.31
Absract
Effects of phorbol myristate acetate (PMA), dibutyryl cyclic AMP
(dbcAMP), 6-dimethylaminopurine (6-DMAP) and okadaic acid (OA)
on plasminogen activator (PA) activity and maturation rate in vitro
in bovine oocyte-cumulus cell complexes (BOCC) were determined.
Three plasminogen-dependent lytic zones (92-95 kD, 71-73 kD and
49-51 kD) were detected by SDS-PAGE and zymography in matured
BOCC and reverse zymography revealed a PA inhibitor (PAI, 52 kD).
Activity in the 49-51 kD band was reduced by amiloride suggesting
a urokinase-type PA (uPA) and the 71-73 and 92-95 kD bands are a
tissue-type PA (tPA) and tPA-PAI complex, respectively.Dibutyryl
cyclic AMP increased (P<0.05) PA activity in BOCC in dose-
dependent fashion.Phorbol myristate acetate increased (P<0.05)
uPA activity, and at high concentration, tPA activity,in BOCC.
Neither dbcAMP nor PMA inhibited (P>0.05) germinal vesicle
breakdown (GVBD).Plasminogen activator activity decreased in 6-
DMAP and oocyte maturation was inhibited in dose-dependent
fashion (P<0.05). Plasminogen activator and PAI activities markedly
increased (P<0.05) in BOCC treated with up to 25 nM OA, however
activities decreased (P<0.05) at concentrations greater than 75 nM.
These data suggest that PA and PAI production by BOCC is
associated with GVBD and influenced by stimulators of the protein
kinase A and C systems and modulators of intracellular
phosphorylation.32
Introduction
Plasminogen activators (PA) are serine proteases that convert
the zymogen, plasminogen, into plasmin.Two principal PA have
been identified, tissue-type (tPA) and urokinase-type (uPA), and
their activities are modulated physiologically by several different
inhibitors, including PA inhibitors-1(PAI-1), -2 (PAI-2) and -3
(PAI-3) (Dano et al., 1985; Kruithof, 1988).Plasminogen activators
and PAI are synthesized and secreted by numerous cell types, often
under hormonal control, and are thought to play an important role in
the extracellular proteolysis accompanying cell migration and
tissue remodelling (Dano et al., 1985; Andreasen et al., 1990;
Mullins et al., 1983)In the ovary, PA activity is markedly
increased in granulosa cells obtained from follicles shortly before
ovulation (Beers et al., 1975).Rat granulosa and cumulus cells
secrete PA in response to gonadotrophins (Ny et al., 1985; Canipari
et al., 1986) and itis believed that granulosa cell tPA contributes
to follicle rupture (Liu et al., 1987).Rat and mouse oocytes
denuded of cumulus cells produce only tPA during spontaneous in
vitro meiotic maturation (Huarte et al.,1985), however cultured
oocyte-cumulus cell complexes produce both tPA and uPA (Liu et al.,
1986). Interestingly, in rats, FSH and GnRH stimulate tPA, butnot
uPA, activity in both cell types when culturedas oocyte-cumulus
cell complexes (Liu et al., 1986; Ny et al., 1987).Ny et al. (1987)
have suggested that GnRH treatment increases PA activity inrat
oocyte-cumulus cell complexes through the protein kinase C
pathway. On the other hand, FSHappears to mediate its effects
through the cAMP-dependent protein kinase A pathway (Salustriet33
al., 1985).Both phorbol myristate acetate (PMA), a stimulator of
the protein kinase C pathway (Castagna et al., 1982), and dibutyryl
cAMP (dbcAMP) can increase PA activity in a variety of cell types
(Dano et al., 1985).Although PA activity is increased inrat oocyte-
cumulus cell complexes in vitro by hormones, it has not been
determined in oocyte-cumulus cell complexes from cattleif PA is
present, and if produced, whether activity is regulated by second
messenger systems.
Phosphorylation and dephosphorylation of proteins playsan
important rolein the cell cycle and oocyte maturation (Draetta et
al., 1988; Moor and Crosby, 1986)The cdc protein, p34cdc2, is the
key protein kinase component of maturationor M-phase promoting
factor (MPF) that controls the transition from G2 to M phase in both
meiosis and mitosis (Masui and Markert, 1971;Draetta et al.,1989).
The activity of p34cdc2 is regulated by phosphorylation (Dunphyand
Newport, 1988; Gautier et al., 1989).It has been shown recently
that 6-dimethylaminopurine (6-DMAP),a serine/threonine protein
kinase inhibitor (Meijer and Pondaven, 1988; Neant and Guerrier,
1988), inhibits germinal vesicle breakdown (GVBD) inmouse (Rime
et al., 1989) and bovine oocytes (Fulka et al., 1991).In contrast,
okadaic acid (OA), a potent inhibitor of phosphatases 1 and2A
(Bialojan and Takai, 1988), induces meiotic maturationand MPF
activation when microinjected into Xenopus andmouse oocytes
(Jessus et al., 1991; Gavin et al., 1991).Okadaic acid is also a
potent inducer of the uPA gene through a mechanism independentof
the protein kinase A and C systems (Nagamine and Ziegler,1991).
Despite this information in other species, nothing isknown about34
the role of protein phosphorylation on PA activityin bovine oocytes
matured in vitro. Therefore, the objective of this studywas to
investigate the effects of dbcAMP, PMA, 6-DMAP and OAon PA
activity and maturation ratein bovine oocyte-cumulus cell
complexes (BOCC) matured in vitro.
Materials and Methods
Recovery and Culture of BOCC
Cattle ovaries were collected from a local slaughterhouse and
transported to the laboratory in physiological saline (25-30 C)
within 2 h. Oocytes were aspirated from 2- to 5-mm folliclesand
washed with Tissue Culture Medium 199 (TCM199, Sigma Chemical
Co., St. Louis, MO, USA) supplemented with polyvinylpyrrolidone
(PVP, 3 mg/ml, Sigma), sodium pyruvate (50 mg/ml), sodium
bicarbonate (2.6 mg/ml) and 10 m1/Iof an antibiotic-antimycotic
solution (Sigma).Oocytes were pooled and carefully selected under
a stereomicroscope and only those with compact cumulus were
used. Oocytes were cultured in TCM199 modifiedas above at 39 C in
a humidified 5% CO2 in air atmosphere (Saiki et al., 1991).
Experimental Treatments
Determination of the optimum number of BOCC and thetime
course for PA detection.Ten, twenty and thirty BOCCwere initially
used to evaluate the optimum number of BOCC requiredto produce
satisfactory zymograms.The time course required for development
of activity was determined by in vitro culture oftwenty BOCC for
0, 6, 12 and 24 h.All subsequent experiments also used twenty
BOCC for each treatment.35
Dibutyryl cAMP. A stock solution of 25 µg/ml dbcAMP (Sigma)
in TCM199 was used.This solution was diluted with culture
medium to concentrations of 0.5, 1 and 2.5 mM.
Phorbol myristate acetate.Phorbol 12-myristate 13-acetate
(Sigma) was used in concentrations of 1, 10 and 100 ng/ml and
diluted from a 10 µg/m1 stock solution dissolved in
dimethylsulfoxide (DMSO, Sigma).Each final dilution of PMA
contained 1% DMSO and medium with 1% DMSO servedas a control.
6-Dimethylaminopurine. A stock solution of 100 mM 6-
dimethylaminopurine (Sigma) in TCM199 was used in these
experiments.This solution was diluted with culture medium to 0.2,
1 and 2 mM concentrations.
Okadaic acid.Okadaic acid (Moana Bioproducts, Honolulu, HI,
USA) was diluted with TCM199 to a concentration of 25 µg/ml.This
stock solution was diluted with culture medium to 2.5, 7.5, 25, 75
and 250 nM.
Electrophoresis and Zymography
Electrophoresis and zymography were performed using the
procedures described by Granelli-Piperno and Reich (1978) and
Vassal lietal.(1984) with modifications.Twenty oocytes with
evenly enclosed cumulus cells were combined with 90 µl ofsample
buffer (5.0% SDS; 20% glycerol; 0.0025% bromophenol blue in
0.125M Tris HCI buffer).Each polyacrylamide gel includedone lane
containing the following molecular mass standards:phosphorylase
b (97.4 kD), bovine serum albumin (66.2 kD), ovalbumin(45.0 kD),
carbonic anhydrase (31.0 kD), soybean trypsin inhibitor(21.5 kD)
and lysozyme (14.4 kD) (Bio-Rad Laboratories, Richmond, CA,USA)36
and one lane with either human tPA (Sigma)or urokinase (American
Diagnostica, Inc., Greenwich, CT, USA). One hundred microlitersof
BOCC samples, urokinase, tPA or MW standardswere pipetted into
castellated wells in a 4% stacking gel witha 12% separating gel.
Electrophoresis was conducted at 20 mA through thestacking gel
and 30 mA through the separating gel for 2 to 4 h.
Following electrophoresis, the polyacrylamide gelswere gently
shaken in 2.5% Triton X-100 (Sigma) in H2O for 30 min,rinsed with
distilled water and incubated in DPBS for 30 min.The gel was
placed on plastic wrap and a casein-agar gel containingpurified
human plasminogen (Sigma) supportedon a glass plate (the
zymogram) was applied to the surface of thepolyacrylamide gel.
Zymograms were prepared by dissolving 4g of nonfat dry milk
(Carnation Co., Los Angeles, CA, USA) in 100ml of buffer containing
0.0013 M CaCl2 2H20, 0.1 M glycine, 0.038 M Trisand 0.005 M Na
azide.Seven milliliters of the nonfat dry milk mixturewere heated
to 55 C and combined with 7.0 ml of 2% meltedagarose (Sigma)
with distilled water also maintained at 55 C.Purified human
plasminogen was added to the warmed mixture of4% nonfat dry
milk and 2% agarose to yielda final concentration of 25-30 µg /ml
and 10 ml of this mixture was cast ontoa warmed 13 X 6 cm glass
plate.Zymograms containing 0 µg /ml plasminogenwere also used
for detection of any nonspecific proteolyticactivity.The gel
sandwich (acrylamide gel and casein-agargel) was incubated at 39
C for 24-48 h.Plasminogen activator migrationwas determined
during the incubation period and after fixingthe gel by measuring
the distance from the edge of the separatinggel to the center of the37
lytic bands in each lane. Zymogram incubationwas terminated by
separating the gels, fixing the zymogram with 3% acetic acid for 10
min, and rinsing under tap water.Zymograms were dried and
stained with 0.1% Amido Black (Bio-Rad) for permanent storage
(Lowenstein and Inglid, 1976).Polyacrylamide gels were stained
overnight with 0.05% Coomassie Brilliant Blue (Bio-Rad) in
65:25:10 water:isopropanol:acetic acid and destained with 80:10:10
water:isopropanol:acetic acid.Molecular masses of PA were
determined from the regression calculations of log molecularmass
and relativemobility.
Reverse zymograms were prepared according to Erickson et al.
(1984).Briefly, zymograms were prepared as regularzymograms
except 500 ul of purified 5 IU/m1 urokinase (American Diagnostica,
Inc.) was added.The gel sandwich (acrylamide gel and casein-agar
gel) was incubated at 39 C for 3-5 h until lysis occurred.
Zymograms containing amiloride (Vassalli and Belin, 1987)
were prepared by combining 50:50 4.4% nonfat dry milk in buffer
with 2.2% melted agarose indistilled water. Nine millilitersof this
solution were combined with1ml of either 0 or 100 mM amiloride
(Sigma) in phosphate buffered saline (PBS).Plasminogen was added
to a final concentration of 25-30 1.1g/m1 and the warmed mixture
cast onto a 13 X 6 cm glass plate.The plate containing 0 mM
amiloride was used as the control plate.
Assessment ofIn Vitro Maturation
At the termination of culture, thirty to fifty BOCCfrom each
treatment were fixed and stained for assessment of meioticstage.
Cumulus cells were first removed from oocytes byvigorous38
vortexing for 1-2 min.The denuded oocytes were washed twice in
2.0% sodium citrate, transferred to 0.7% sodium citrate for 3 min,
fixed onto microscope slides with 25% acetic acid in ethanol, air
dried (McGaughey and Chang, 1969) and stained with hematoxylin
and eosin.Oocytes were evaluated for meiotic stage using bright-
fieldmicroscopy.
Data Analysis
All experiments measuring PA and PAI activitywere repeated
at least three times.Protease activity was quantified by
densitometric scanning of the zymogram using the Model 1650
reflectance/transmittance scanning densitometer (Bio-Rad) and
computing software (Hoefer Scientific Instruments, San Francisco,
CA, USA). A polar planimeter (model L-20-M; Lasico, Los Angeles,
CA, USA) was used to trace the densitometricscans and determine
areas of the lytic zones.Results are expressed relative to the
control treatment where the lytic area is set to 1.0.Differences in
PA activities in each experiment were determined by analysis of
variance and Duncan's multiple range test.Differences in oocyte
maturation rates were determined using Chi-square procedures.All
analyses were conducted using the NCSS statistical software
program (Number Cruncher Statistical System 4.01, 1984, Hintze,
JL, Kaysville, UT).
Results
Plasminogen Activator Activities in BOCC During In Vitro
Maturation39
Three plasminogen-dependent lytic zones (92-95 kD, 71-73 kD
and 49-51 kD) were observed in in vitro matured BOCC (Figure1-1).
Addition of amiloride, a competitive inhibitor of uPA, to the
zymogram eliminated the 49-51 kD band suggesting itis an uPA and
the 71-73 and 92-95 kD bands are a tPA and tPA-PAI complex,
respectively (Figurel-1).Ten, twenty and thirty BOCC were used to
evaluate the optimum number of BOCC required to provide suitable
caseinolysis. Tissue-type PA and uPA activity increased gradually
but not significantly (P>0.10, Figure 1-2)as BOCC number increased,
however, tPA-PAI complex activity increased (P<0.05) between 10
and 20 BOCC.Plasminogen activator activity increased ina time-
dependent fashion (Figures 1-3 and 4), andas shown in figure 1-4, a
significant increase (P<0.01) was observed between 6-12 h of
culture.In addition, tPA and tPA-PAI activity increased (P<0.05)
more rapidly than uPA during in vitro maturation.
Effects of dbcAMP and PMA on PA Production by BOCC
The effects of dbcAMP on PA activity and maturationrate of
BOCC were determined by in vitro culture with 0, 0.5,1.0 and 2.5
mM dbcAMP for 24 h.As seen in Figures 1-5 and 6, PA activities
increased in a dose-dependent fashion (P<0.05).To determine
whether an activator of the protein kinase C systemcan modulate
PA production, BOCC were cultured with PMA for24 h.One percent
DMSO, which was used to dilute PMA, hadno effect on PA production
during maturation in vitro (Figures 1-5 and 6).Increasing PMA in
culture medium (1, 10 and 100 ng/ml) increased(P<0.05) uPA and
tPA production by BOCC (P<0.05), but hadno effect on tPA-PAI
complex activity (P>0.10).Neither PMA nor dbcAMP inhibited40
(P>0.10) GVBD (Figures 1-8 and 9), however, progression to
metaphase II was inhibited by high concentrations of these reagents
(100 ng/ml PMA and 1 and 2.5 mM dbcAMP).
Effects of 6-DMAP and OA on PA Production by BOCC
In BOCC cultured with 0, 0.2,1 and 2.0 mM 6-DMAP, the three
forms of PA activity decreased (P<0.05) in dose-dependent fashion
(Figures 1-9 and 10). Oocyte maturation rate was also inhibited
(P<0.01; Figure I-8A) by 6-DMAP and at a concentration of 2 mM,
both GVBD and PA activity were almost completely suppressed.
When BOCC were treated with OA a new plasminogen-dependent
lytic band (84-86 kD) appeared (Figure 1-11).This novel band was
amiloride-sensitive suggestingit may be a uPA-PAI complex
(Figure 1-12).The uPA-PAI and uPA activities increased (P<0.05) in
BOCC treated with up to 25 nM OA, however at concentrations
greater than 75 nM PA activity decreased (P<0.05, Figure 1-13). The
tPA and tPA-PAI band increased up to 7.5 nM OA, but decreased
thereafter (P<0.05).Oocyte maturation was also inhibited by OA at
concentrations greater than 75 nM (P<0.05, Figure 8d).
PA Inhibitor in BOCC
Reverse zymography revealed a plasminogen activator inhibitor
(PAI, 52 kD) in 20 BOCC cultured for 24 h (Figure 1-14). When BOCC
were treated with 25 nM OA, PAI activity increased four to five-
fold compared to 0 nM OA (P<0.01, Figure 1-15).Plasminogen
activator inhibitor activity was also increased in BOCC treated
with 2.5 mM dbcAMP and 2.5 nM OA (P<0.05), however PAI activity
was inhibited by 250 nM OA and 2 mM 6-DMAP (P<0.05).41
Discussion
Zymographic analysis revealed that in vitromatured BOCC
produced three plasminogen dependent proteases (49-51 kD, 71-73
kD and 92-95 kD) and one PAI (52 kD) during in vitro maturation.
Low molecular PA activity (49-51 kD) is likely uPA because thisPA
activityis completely inhibited by amiloride,a specific and
competitive inhibitor of uPA (Vassal li and Be lin,1987).The
molecular mass of the 49-51 kD species also corresponds to the
values reported by Dano et al. (1985) for uPA of 31-55 kD.The 71-
73 kD and 92-95 kD species were resistant to amiloride treatment
suggesting tPA and a tPA-PAI complex, respectively. Tissue-type
PA is synthesized as a proenzyme witha MW of approximately 70 kD
and composed of two polypeptide chains, a heavy chain (40 kD)and
light chain (30 kD), linked by a single disulfie bond (Degenet al.,
1986).Plasminogen activator inhibitors are a family of specific
inhibitors of PA.The PAI can form complexes with either uPAor
tPA that are resistant to breakdown by SDS (Degenet al., 1986).
Hence, when analyzed by zymography, ifa PAI is present with PA,
PA-PAI complexes can be formed that will induce caseinolysisin a
high molecular mass range (Degen et al., 1986).Typically
complexes between serine proteases and serineprotease inhibitors
(serpins) are of lower molecularmass than would be
mathematically expected, due to release ofa cleavage fragment
upon association (Wiman and Collen, 1979).Rehemtulla et al.
(1990) reported a 92 kD PA in human K562 cellswhen they added
excess urokinase (52 kD) to the culture medium, suggesting that the
molecular mass of the binding proteinwas 40 kD.However, reverse42
zymography showed a PAI with a molecular mass of 45kD.
Collectively, these findings suggest that when PA interacts with
PAI, some portion of the PAI may be cleaved, thus leavinga complex
of mathematically lower molecular mass than would be expected.
The function of PA in cumulus-oocytes complexes is unclear.
However it has been suggested that PA is involved in several
processes, including folliclerupture, oocyte maturation, cumulus
cell expansion and dispersion, fertilization and thezona reaction
(Huarte et al., 1987;Bicsoket al., 1989).In this study PA activity
inBOCCincreased in a time-dependent fashion during in vitro
maturation with significant increases between 6 and 12 h of
culture.In bovine oocytesGVBDoccurs between 4 and 8 h of
culture (Sirard et al., 1989).Our observations suggest that PA
induction inBOCCoccurred shortly afterGVBDand it may be
associated with the process of oocyte maturation.
The PAI observed in our study possesses several similarities
with PAI-1. At least three classes of PAI have been identifiedon
the basis of immunochemical reactivity and recombinant DNA
probes (Hart and Rehemtulla, 1988).Plasminogen activator
inhibitor-1is a 52 kD glycoprotein which is synthesized by
endothelial cells, hepatocytes and platelets, and is present in
plasma. Plasminogen activator inhibitor-1inhibits tPA, as well as
uPA, by forming SDS-stable complexes.Plasminogen activator
inhibitor-2is synthesized by various tissues including the placenta
and macrophages.Unlike PAI-1, PAI-2 exists in two different
forms.Intracellularly, PAI-2 exists as a nonglycosylated molecule
with a molecular mass of 47 kD, whereas the secretedform is43
glycosylated and has a molecular mass of 60 kD.Plasminogen
activator inhibitor-2is a more selective inhibitor of uPA whereas
PAI-1 has a higher binding affinity for tPA.Plasminogen activator
inhibitor-3 is predominately found in urine and plasma and hasa
molecular mass of 51 kD.Plasminogen activator inhibitor-3 has
recently been reported to be identical to the inhibitor of activated
protein C.
Dibutyryl cAMP, a known inducer of cAMP-dependent protein
kinase A, has been found to stimulate PA production by promoting
the transcriptional activity of the PA gene (Nagamine et al.,1983).
Rat granulosa cells secrete mainly tPA, whereasmouse cells
secrete predominately uPA (Canipari et al., 1987). Mouse uPA and
rat tPA in granulosa cells are stimulated by gonadotropins,
prostaglandin E2, and dbcAMP. In our study, dbcAMP increasedboth
tPA and uPA activity in BOCC ina dose-dependent fashion.
Phorbol 12-myristate 13-acetate, a potent tumorpromoter, has
been found to enhance PA activity presumably through the
activation of phospholipid-dependent protein kinase C (Vassalliet
al., 1977; Quigley, 1979).In the present research, the possibility
thatBOCC utilize protein kinase C in regulating PA productionwas
investigated.Phorbol myristate acetate increased uPA and tPA
production by BOCC but had no effecton tPA-PAI complex and PAI
activities when compared to the DMSO control.Phorbol esters have
been shown to stimulate RNA synthesis (Sivak and VanDuurren,
1970) and enhance protein synthesis (Hiwasaet al., 1982).The
effect of PMA on PA production in BOCC reported hereinmay be due
to stimulation of proteinsynthesis in cumulus cells, however44
further investigationis required to elucidate the mechanism by
which PMA preferentially increased uPA activity.Although high
concentrations of dbcAMP (1.0 and 2.5 mM) and PMA(100 ng/ml)
inhibited progression to metaphase II,neither dbcAMP nor PMA
inhibited GVBD in BOCC. Spontaneous meioticmaturation of denuded
mouse oocytes is prevented by high concentrations of dbcAMP (Cho
et al., 1974; Ecay and Powers, 1990).
As shown in our study, PA activity in BOCCwas effectively
inhibited and GVBD was also completely blockedwhen BOCC were
exposed to 2 mM 6-DMAP.6-Dimethylaminopurine blocks
phosphorylation without affecting protein synthesis(Neant and
Guerrier, 1988).Phosphorylation and dephosphorylationprocesses
have been known to playan important role in MPF activity which
controls the transition of meioticor mitotic cells from G2 phase to
M phase.Our results showed that the effective dose ofthis drug (2
mM) inhibited not only plasminogen-dependentprotease activities
but PAI activity as well.Previous research showed that PAI isan
important modulator of PA activity.Politis et al. (1990)
demonstrated that the increase in PA activityassociated with
follicular rupture in thesow ovary is due to an increase in
follicular tPA-like content anda reduction in content of a PAI-1
type protein.Liu et al. (1991) reporteda coordinated regulation of
PAI-1 and tPA activities and mRNA levelsin the ovary such thata
peak of PA activity occurred just priorto ovulation.Our results
demonstrate that the decrease of PA activityby 6-DMAP is not by
modulating PAI activity.45
Okadaic acid is a potent inhibitor of both protein phosphatases
1 and 2A.In this study OA induced new plasminogen-dependent
protease activity (84-86 kD) in BOCC matured in vitro.Addition of
amiloride to the zymograph eliminated this band suggestingit may
be an uPA-PAI complex.A study from our laboratory reported that
day 12-14 cattle embryos produced two plasminogen-dependent
lytic zones, a light form of 41.5-47 kD and a heavy form of 86.1-92
kD (Dyk and Menino, 1991).Subsequent results demonstrated that
PA activity could be completely suppressed by amiloride and
antibodies to human uPA whereas PA activity was unchanged with
antibodies to human tPA suggesting the heavy form may be a uPA-
PAI complex (Berg and Menino, 1992).Our results demonstrated a
four- to five-fold increase in PAI activity as well as a six- to
seven-fold increase in uPA activity in BOCC treated with 25 nM OA
compared to 0 nM OA. These results would explain the increased
uPA-PAI complex activity observed in BOCC treated with 25 nM OA.
Plasminogen activator activities were highest in tPA and tPA-PAI
complex at 7.5 nM OA whereas uPA and uPA-PAI complex activities
reached acmes at 25 nM OA.In cell-free extracts, OA inhibits
protein phosphatase 2A at low concentrations (0.1 nM) and protein
phosphatase 1at high concentrations (10 nM) (MacKintosh and
Cohen, 1989).Nagamine and Ziegler (1991) reported that a high
concentration of OA (125 nM) induced uPA mRNA accumulation in
LLC-PK cells, a cell line derived from porcine renal proximal tubule
epithelia.The response of uPA, tPA and PAI activities to 25 nM OA
may well be due to the differential dose effects of OA on
phosphatases 1 and 2A.In BOCC kinases may be responsible for46
inducing uPA and tPA activities whereas phosphatase 1suppresses
PAI and uPA and phosphatase 2A suppresses tPA expression.
Maturation promoting factor activation can be induced by OA
through inhibition of phosphatase 2A (Felix et al., 1990) and in
Xenopus and mice, MPF activation has been characterized under OA
microinjection (Jessus et al., 1991; Gavin et al., 1991).Despite 25
nM OA strikingly increasing PA activity, no effectwas observed on
bovine oocyte maturation rate in vitro.However, both oocyte
maturation rate and PA activity were inhibited by OA at
concentrations greater or equal to 75 nM.
In conclusion, these data suggest that production of PA and PAI by
BOCC is temporally associated with in vitro maturation and
influenced by stimulators of the protein kinase A and C systems and
modulators of intracellular phosphorylation.The physiological
roles of PA and PAI in the oocyte-cumulus cell complex remain
unclear and additional work is warranted to elucidate the
involvement of the PA-PAI system in oocyte maturation and
fertilization.Figure 1-1.Zymographic analysis of in vitro matured BOCC.
Zymogram with 0 mM (lane 1) and 10 mM amiloride (lane 2).
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Figure 1-2.Plasminogen activator activities in 10, 20or 30 BOCC
after 24 h of culture.Results are the means ± SE of threeseparate
experiments and are expressed relativeto the PA activity of 10
BOCC.Means without common superscriptsare different (P<0.05).
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Figure 1-3.Zymographic analysis of in vitro matured BOCCat 0
(lane 1), 6 (lane 2), 12 (lane 3) and 24 h (lane 4) of culture.
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Figure 1-4.Plasminogen activator activities associated withBOCC
at 0, 6, 12 and 24 h of culture.Results are the means ± SE of three
separate experiments and are expressed relative to thePA activity
of BOCC at 0 h.Means without common superscriptsare different
(P<0.05).
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Figure 1-5.Zymographic analysis of in vitro matured BOCC cultured
in 2.5 (lane 1), 1.0 (lane 2), 0.5 (lane 3) and 0 (lane 4) mM dbcAMP
and 100 (lane 5), 10 (lane 6) and 1 (lane 7) ng/ml PMA, 1% DMSO
(lane 8) and 0% DMSO (lane 9).
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Figure 1-6.Effects of dbcAMP on PA activities inin vitro matured
BOCC. Results are the means ± SE of three separate experiments and
are expressed relative to the PA activity of BOCC in 0 mM dbcAMP.
Means without common superscripts are different (P<0.05).
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Figure 1-7.Effects of PMA on PA activities inin vitro matured
BOCC. Because PMA was dissolved in 1% DMSO, medium with0 or
1% DMSO was used for comparison.Results are the means ± SE of
three separate experiments expressed relative to the PA activityof
BOCC in 0% DMSO. Means withoutcommon superscripts are
different (P<0.05).
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Figure 1-8.Effects of dbcAMP, PMA, 6-DMAP and OAon germinal
vesicle breakdown (GVBD) and development to metaphase II(M11).
Bovine oocyte-cumulus cell complexes were cultured in a) 0,0.5,1
and2.5mM dbcAMP; b) 0 or 1% DMSO, 1, 10 or 100 ng/ml PMA, c) 0,
0.2, 1and2mM 6-DMAP; d) 0,2.5, 25and250nM OA. Percentages
without common superscripts are different (P<0.05).
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Figure 1-9.Zymographic analysis of in vitro matured BOCC cultured
in 2.0 (lane 1), 1.0 (lane 2), 0.2 (lane 3) and 0 (lane 4) mM 6-DMAP
and BOCC at 0 h of culture (lane 5).
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Figure 1-10.Effects of 6-DMAP on PA activitiesinin vitro
matured BOCC. Resultsare the means ± SE of three separate
experiments and are expressed relativeto the PA activity of BOCC
in 0 mM 6-DMAP.Means without common superscriptsare different
(P<0.05).
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Figure 1-11.Zymographic analysis of in vitro matured BOCC
cultured in 0 (lane 1), 2.5 (lane 2), 7.5 (lane 3), 25 (lane 4), 75 (lane
5) and 250 nM OA (lane 6).
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Figure 1-12.Zymographic analysis of in vitro matured BOCC
cultured in 25 nM OA (lanes 1 and 4).Lanes 2 and 5 contain 0.1
1U/m1 human urokinase and lanes 3 and 6 contain 5 ng/ml human
tPA.Lanes 1, 2 and 3 are in the zymogram with 0 mM amiloride, and
lanes 4, 5 and 6 are in the zymogram with 10 mM amiloride.
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Figure 1-13.Effects of OA on PA activities in in vitro matured
BOCC. Results are the means ± SE of threeseparate experiments
and are expressed relative to the PA activity of BOCCin 0 nM OA.
Means without common superscriptsare different (P<0.05).
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tPA-PAI uPA-PAItPA uPAFigure 1-14.Reverse zymographic analysis of in vitro matured
BOCC. BOCC were cultured in medium only (lane 1), 1% DMSO (lane
2), 100 ng/ml PMA (lane 3), 2.5 mM dbcAMP (lane 4), 2 mM 6-DMAP
(lane 5), 2.5 nM OA (lane 6), 25 nM OA (lane 7) and 250 nM OA (lane
8).
1 2 3 4 56 78 KD
-97
-66
-4361
Figure 1-15.Plasminogen activator inhibitor activitiesininvitro
matured BOCC. Results are the means ± SE of three separate
experiments and are expressed relative to the PAI activity of BOCC
in the control medium. Treatments included:control medium, 1%
DMSO, 100 ng/ml PMA, 2.5 mM dbcAMP, 2 mM 6-DMAP, 2.5 nM OA, 25
nM OA and 250 nM OA. Means without common superscriptsare
different (P<0.05).
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EFFECTS OF STIMULATORS OF PROTEIN KINASE A AND C AND
MODULATORS OF PHOSPHORYLATION ON PLASMINOGEN ACTIVATOR
ACTIVITY IN PORCINE OOCYTE- CUMULUS CELL COMPLEXES
MATURED IN VITRO.70
Abstract
Effects of phorbol myristate acetate (PMA), dibutyryl cyclic
AMP (dbcAMP), 6-dimethylaminopurine (6-DMAP) and okadaic acid
(OA) on plasminogen activator (PA) activity and maturationrate in
porcine oocyte-cumulus cell complexes (POCC) matured in vitro
were determined.Cumulus cell-enclosed oocytes were collected
from 1-4 mm antral follicles and cultured in TCM-199 with 0.3%
polyvinylpyrrolidone for 48 h.Plasminogen activator activityin
POCC was measured using SDS-PAGE, casein-agar zymography and
densitometry.Two plasminogen-dependent lytic zones (93-96 kD
and 71-78 kD) were observed in matured POCC.Addition of
amiloride, a competitive inhibitor of uPA, to the zymograph failed
to reduce activities in either zone suggesting the 71-78 kD band is
a tPA and the 93-96 kD band is possibly a tPA-PAI complex.
Changes in PA activity due to the various treatmentswere
expressed relative to the PA activity in 40 POCC.Increasing
dbcAMP in the culture medium (0.5, 1 and 2.5 mM) increased
activity in a dose-dependent fashion (P<0.05).Concentration of 10
and 100 ng/ml PMA inhibited PA activity by POCC (P<0.05).Either
PMA or dbcAMP inhibited oocyte maturation (P<0.05).Plasminogen
activator activity decreased (P<0.05) in 6-DMAP and oocyte
maturation was inhibited (P<0.05) in a dose-dependent fashion.
When POCC were treated with 25 nM OAa new plasminogen
-dependent lytic band (49-52 kD) appeared.This novel band was
amiloride-sensitive suggestingitis an uPA.Plasminogen activator
activity increased (P<0.05) in POCC treated withup to 25 nM OA,
however PA activity decreased (P<0.05) at concentrationsgreater71
than 75 nM, These data suggest that PA production by POCC is
influenced by the protein kinase A and C systems and kinase
inhibitors during oocyte maturation.Inhibitionofintracellular
phosphatases also induced novel PA production.
Introduction
Plasminogen activators (PA) are serine protease that convert
the zymogen, plasminogen, into plasmin.Plasminogen activators
are involved in a variety of physiologic processes including
fibrinolysis, ovulation, mammary involution and implantation (Dano
et al., 1985).Two types of PA have been characterized by
molecular mass, tissue-type (tPA) and urokinase-type (uPA) PA.
Rat and mouse oocytes produce only tPA during spontaneous in vitro
meiotic maturation (Huarte et al.,1985), however cultured oocyte
-cumulus cell complexes (OCC) produce both tPA and uPA (Liu et
al.,1986).In rats, FSH and GnRH stimulate tPA, but not uPA,
activity in both cell types when cultured as OCC (Liu et al., 1986;
Ny et al. 1987).Ny et al. (1987) have suggested that GnRH
treatment increases PA activity inrat OCC through the protein
kinase C pathway, whereas FSH appears to mediate its effects
through the protein kinase A pathway (Salustri et al. 1985).
Although PA activityis increased inrat oocyte-cumulus cell
complexes by stimulators of the protein kinase A and C systems, it
has not been determined if porcine OCC (POCC) produce PA and if
present, whether activity can be regulated by second messenger
systems.72
Cycles of cellular phosphorylation and dephosphorylation have
important roles in maturation or M-phase promoting factor (MPF)
activity involved in the cell cycle and oocyte maturation (Draetta
and Beach, 1988; Moor and Crosby, 1986).Inhibition of protein
phosphorylation by 6-dimethylaminopurine (6-DMAP) (Meijer and
Pondaven, 1988; Neant and Guerrier, 1988) inhibits germinal
vesicle breakdown (GVBD) in mouse (Rime et al., 1989) and bovine
oocytes (Fulka et al., 1991).Okadaic acid (OA), a potent inhibitor
of phosphatases 1 and 2A (Bialojan and Takai, 1988), induces
meiotic maturation and MPF activity when microinjected into
Xenopus and mouse oocytes (Jessus et al.,1991; Gavin et al., 1991).
Okadaic acid is also a potent inducer of the uPAgene through a
mechanism independent of the protein kinase A and C systems
(Nagamine and Ziegler, 1991).Despite this information,
known about the role of protein phosphorylationon PA activity in
porcine oocytes matured in vitro.Therefore, the objective of this
study was to investigate the effects of dbcAMP, PMA, 6-DMAP and
OA on PA activity in POCC matured in vitro.
Materials and Methods
Recovery and Culture of POCC
Porcine ovaries were collected from a local slaughterhouse
and transported to the laboratory in physiological saline (25-30C)
within 2 h.Oocytes were aspirated from 1- to 4-mm follicles and
washed with Tissue Culture Medium 199 ( TCM199, Sigma Chemical
Co., St. Louis, MO, USA) supplemented with polyvinylpyrrolidone73
(PVP, 3 mg/ml, Sigma), sodium pyruvate (50 1.1g/m1), sodium
bicarbonate (2.6 mg/ml) and 10 mI /Iof an antibiotic- antimycotic
solution (Sigma).Oocytes were pooled and carefully selected under
a stereomicroscope and only those with two or three layers of
cumulus cells were used.Porcine oocyte-cumulus cell complexes
were allocated randomly to the experimental treatments and those
with distinct granulosa cells were not used.Oocytes were cultured
in TCM199 modified as above at 39 C in a humidified 5% CO2 in air
atmosphere (Saeki et al., 1991).
Experimental Treatments
Determination of the optimum number of POCC and the time course
for PA detection.Twenty, forty and sixty POCC were initially used
to evalute the optimum number of POCC required to produce
satisfactory zymographs.The time course required for
development of activity was determined by invitro culture of forty
POCC for 0, 12, 24, 36 and 48 h.All subsequent experiments also
used forty POCC for each treatment.
Dibutyryl cAMP. A stock solution of 25 µg /ml dbcAMP (Sigma) in
TCM199 was used.This solution was diluted with culture medium
to concentrations of 0.5,1 and 2.5 mM.
Phorbol myristate acetate.Phorbol 12-myristate 13-acetate
(Sigma) was used in concentrations of 1, 10 and 100ng /mI and
diluted from a 10 µg /ml stock solution dissolved in
dimethylsulfoxide (DMSO, Sigma).Each final dilution of PMA
contained 1% DMSO and medium with 1% DMSO servedas the
control.74
6-Dimethylaminopurine.A stock solution of 100 mM 6-DMAP
(Sigma) in TCM199 was used in these experiments.This solution
was diluted with culture medium to 0.5,1 and 2 mM concentrations.
Okadaic acid.Okadaic acid (Sigma) was diluted with TCM199 to a
concentration of 25 µg /ml.This stock was diluted with culture
medium to 2.5, 7.5, 25, 75 and 250 nM.
Electrophoresis and Zymography
Electrophoresis and zymography were performed using the
procedures described by Dyk and Menino (1991) which were
modified from Granelli-Piperno and Reich (1978) and Vassal liet al.
(1984).Forty oocytes with evenly enclosed cumulus cells were
combined with 90 ul of sample buffer ( 5.0% SDS; 20% glycerol;
0.0025% bromophenol blue in 0.125 M Tris HCI buffer).One hundred
microliters of POCC samples were pipetted into castellated wells
in a 4% stacking gel with a 12% separating gel.Electrophoresis
was conducted at 20 mA through the stacking gel and 30 mA
through the separating gel for 2 to 4 h.Zymographs were prepared
by dissolving 4 g of nonfat dry milk (Carnation Co., Los Angeles, CA,
USA) in 100 ml of buffer containing 0.0013 M CaC12.2H20, 0.1 M
glycine, 0.038 M Tris and 0.05 M Na azide.Seven milliliters of the
nonfat dry milk mixture were heated to 55 C and combined with 7.0
ml of 2% melted agarose dissolved in (Sigma) distilled water and
maintained at 55 C.Purified human plasminogen was added to the
warmed mixture of 4% nonfat dry milk and 2% agarose to yield a
final concentration of 25-30 µg /ml and 10 ml of this mixture was
cast onto a warmed 13X6 cm glass plate.Zymographs containing 075
pig/m1 plasminogen were also used for detection of any nonspecific
proteolyticactivity.
Zymographs containing amiloride (Vassalli and Belin, 1987)
were prepared by combining 50:50 4.4% nonfat dry milk in buffer
with 2.2% melted agarose indistilled water.Nine milliliters of
this solution were combined with1ml of either 0 or 100 mM
amiloride (Sigma) in phosphate buffered saline (PBS).Plasminogen
was added to a final concentration of 25-30 µg /ml and the warmed
mixture cast onto 13X6 cm glass plate.The plate containing 0 mM
amiloride was used as the control plate.
Assessment ofIn Vitro Maturation
At the termination of culture, thirty to fifty POCC from each
treatment were fixed and stained for assessment of meiotic stage.
Cumulus cells were first removed from oocytes by repeated
pipetting.The denuded oocytes were washed twice in 2.0% sodium
citrate, transferred to 0.7% sodium citrate for 3 min, fixed onto
microscope slides with 25% acetic acid in ethanol, air dried
(McGaughey and Chang, 1969) and stained with hematoxylin and
eosin.Oocytes were evaluated for meiotic stage using bright-field
microscopy.
Data Analysis
All experiments measuring PA activity were repeated at least
three times.Protease activity was quantified by densitometric
scanning of the zymograph using the Model 1650
reflectance/transmittance scanning densitometer (Bio-Rad) and
computing software (Hoefer Scientific Instruments, San Francisco,76
CA, USA).A polar planimeter (model L -20 -M; Lasico, Los Angeles,
CA, USA) was used to trace the densitometric scans and determine
areas of the lytic zones.Results are expressed relative to the
control treatment where the lytic area is set to 1.0. Differences
in PA activities in each experiment were determined by analysis of
variance and Fisher's least significant difference procedures.
Differences in oocyte maturation rates were determined using Chi-
square procedures.All analysis were conducted using the NCSS
statisticalsoftwatre program (Number Cruncher Statistical
System 4.01, 1984, Hintze, JL, Kaysville, UT).
Results
Plasminogen Activator Activities in POCC During In Vitro
maturation
Two plasminogen-dependent lytic zones (93-96 kD and 71-79
kD) were observed in in vitro matured BOCC (Figure 11-1).Addition
of amiloride, a competitive inhibitor of uPA, to the zymograph
failed to eliminate activityin either zone suggesting the 71-79 kD
band is a tPA and the 93-96 kD band is possibly a tPA-PAI complex
(Figure 11-1).Twenty, forty and sixty POCC were used to evaluate
the optimum number of POCC required to provide suitable
caseinolysis.Plasminogen activator activity increased (P<0.05) as
POCC number increased (Figure 11-2).Plasminogen activator
activityalso increased (P<0.05) in a time dependent fashion
(Figures 11-3 and 4) and as shown in Figure 11-4, a significant
induction of PA was observed between 12-24 and 24-36 h of
culture.77
Effects of dbcAMP and PMA on PA Production by POCC
The effects of dbcAMP on PA activity were determined by in
vitro culture with 0, 0.5, 1.0 and 2.5 mM dbcAMP for 48 h.As seen
in Figure 11-5, PA activities increased in a dose-dependent fashion
(P<0.05).To determine whether an activator of the protein kinase
C system can modulate PA production, POCC were cultured with
PMA for 48 h.One percent DMSO, which was used to dilute PMA,
had no effect on PA production during in vitro maturation (FigureII
-6).Ten and 100 ng/ml PMA inhibited (P<0.05) tPA production by
POCC (Figure 11-6).Dibutyryl cyclic AMP (2.5 mM) inhibited both
GVBD and progression to metaphase II (P<0.05; Figure 11-7).
Phorbol myristate acetate (100 ng/ml) did not inhibit (P> 0.10)
GVBD, however, progression to metaphase II was reduced (FigureII
-7).
Effect of 6-DMAP and OA on PA Production by POCC
In POCC cultured with 0, 0.5, 1 and 2.0 mM 6-DMAP, PA activity
decreased (P<0.05) in a dose-dependent fashion.At a
concentration of 2 mM, oocyte maturation and PA activitywere
completely suppressed (Figures 11-7 and 8).
When POCC were treated with OA a new plasminogen-dependent
lytic band (52-55 kD) appeared (Figure 11-9 lanes 4 & 5).This
novel band was amiloride-sensitive suggesting it may be a uPA
(Figure 11-10).The tPA and tPA-PAI complex activities increased
(P<0.05) in POCC treated with up to 25 nM OA, however at
concentrations greater than 75 nM PA activity decreased (P<0.05,
Figure 11-11).The uPA activity found ata concentration of 25 nM
OA did not change at the higher concentration of 75 nM. Oocyte78
maturation was also inhibited by OA at concentration of 25 nM
(Figure11-7).
Discussion
Zymographic analysis revealed that in vitro matured POCC
produced two plasminogen dependent proteases (71-79 kD and 93
-96 kD).Both 71-79 kD and 93-96 kD species were resistant to
amiloride treatment suggesting a tPA and a tPA-PAI complex,
respectively.Tissue-type PA is synthesized as a proenzyme with a
MW of approximately 70 kD and composed of two polypeptide
chains, a heavy chain (40 kD) and light chain (30 kD), linked by a
single disulfide bond (Degen et al., 1986).Plasminogen activator
inhibitors are a family of specific inhibitors of PA.The PAI can
form complexes with either uPA or tPA that are resistant to
breakdown by SDS (Hart and Rehemtulla, 1988).Typically
complexes between serine proteases and serine protease inhibitors
(serpins) are of lower molecular mass than would be
mathematically expected, due to release of a cleavage fragment
upon association (Wiman and Collen, 1979; Rehemtulla et al., 1990)
The function of PA in cumulus-oocytes complexes is unclear.
However it has been suggested that PA is involved in several
processes, including follicle rupture, oocyte maturation, cumulus
cell expansion and dispersion, fertilization and thezona reaction
(Huarte et al.,1985; Liu et al., 1986; Huarte et al., 1987; Bicsoket
al., 1989).In this study PA activity in POCC increased ina time-
dependent fashion during invitro maturation with significant
increases between 24 and 36 h of culture.In pig oocytes GVBD79
occurs between 22 and 24 h of culture (Motlik et al., 1976).Our
observations suggest that PA induction in POCC occurred shortly
after GVBD and it may be associated with the process of oocyte
maturation.
Dibutyryl cAMP, a known inducer of cAMP-dependent protein
kinase A, stimulates PA production by promoting the
transcriptional activity of the uPA gene (Nagamine et al., 1983).In
our study, dbcAMP increased tPA activity in POCC in a dose
-dependent fashion.CyclicAMP has a dual effect on regulation of
oocyte maturation (Dekel et al., 1988).According to this
hypothesis, lower levels of cAMP act to maintain meiotic arrest,
while transiently elevated levels of cAMP mediate gonadotropin
action and induce meiotic resumption.The oocyte is coupled to the
surrounding folliclecell through gap-junctional contacts. The
increased cAMP concentration in response to gonadotropins can
interrupt communication in the oocyte-cumulus cell complexes and
reduce the supply of cAMP to the oocytes ( Eppig, 1982).Our
result demonstrated that a high concentration of dbcAMP (2.5 mM)
inhibited oocyte maturation.
Phorbol 12-myristate 13-acetate, a potent tumor promoter, has
been found to enhance PA activity presumably through the
activation of phospholipid-dependent protein kinase C (Vassalli et
al., 1977; Quigley, 1979).In the present research, the possibility
that POCC utilize protein kinase C in regulating PA productionwas
investigated.Phorbol esters have been shown to stimulate RNA
synthesis (Sivak and Van Durren, 1970) and enhance protein
synthesis (Hiwasa et al.,1982).Ny et al. (1987) reported that80
GnRH or PMA increased tPA enzyme activity, but decreased uPA
activity.However, our results showed that high concentrations of
PMA (10 and 100 mg/ml) decreased tPA activity by POCC.
Plasminogen activator activity in POCC was effectively
inhibited and GVBD was also completely blocked when POCC were
exposed to 2 mM 6-DMAP.6-DMAP blocks phosphorylation without
affecting protein synthesis ( Neant and Guerrier, 1988). The cdc
protein, P34cdc2, is the key protein kinase component of MPF that
controls the transition from G2 to M phase in both meiosis and
mitosis( Masui and Markert, 1971; Draetta et al., 1989).Germinal
vesicle breakdown is inhibited by 6-DMAP in mouse (Rime et al.,
1989) and bovine (Fulka et al., 1991) oocytes.
Okadaic acid is a potent inhibitor of both protein
phosphatases 1 and 2A.In this study OA induced new plasminogen-
dependent protease activity (49-59 kD) in POCC matured in vitro.
Addition of amiloride to the zymograph eliminated this band
suggestingitisinall likelihood uPA.In cell-free extracts, OA
inhibits protein phosphatase 2A at low concentrations (0.1 nM) and
protein phosphatase 1at high concentrations (10 nM).Okadaic acid
(125 nM) alone induced uPA mRNA accumulation in LLC-PK cells,a
cellline derived from porcine renal proximal tubule epithelia.
Despite 25 nM OA markedly increasing tPA activity and inducing
uPA production, no effect was observed on porcine oocyte GVBDin
vitro.However, progress to metaphase II was inhibited by 25 nM
OA81
In conclusion, these data suggest that production of PA by
POCC is temporally associated with in vitro maturation and
influenced by stimulators of the protein kinase A and C system and
modulators of intracellular phosphorylation.The physiological
roles of PA in the oocyte-cumulus cell complex remain unclear and
additional work is warranted to elucidate the involvement of the
PA system in oocyte maturation and fertilization.Figure 11-1.Zymographic analysis of in vitro matured POCC.
Zymographs contain 0 mM (lane 1) or 10 mM amiloride (lane 2).
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Figure 11-2.Plasminogen activator activities in 20, 40, 60 POCC
after 48 h of culture.Results are the means ± SE of three separate
experiments and are expressed relative to the PA activity of 20
POCC. Means without common superscriptsare different (P<0.05).
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b
tPA-PAIFigure 11-3.Zymographic analysis of in vitro matured POCC at 0
(lane 1), 12 (lane 2), 24 (lane 3), 36 (lane 4) and 48 h (lane 5) of
culture.
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Figure 11-4.Plasminogen activator activity associated with POCC
at 0, 12, 24, 36 and 48 h of culture.Results are the means ± SE of
three separate experiments and are expressed relative to the PA
activity of 48 h of culture.Means without common superscripts
are different (P<0.05).
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Figure 11-5.Effects of dbcAMP on PA activities inin vitro matured
POCC. Results are the means ± SE of threeseparate experiments
and are expressed relative to the PA activity of 0 mMdbcAMP.
Means without common superscriptsare different (P<0.05).
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Figure 11-6.Effects of PMA on PA activities inin vitro matured
BOCC. Because PMA was dissolved in 1% DMSO, medium with0 or
1% DMSO was used for comparison.Results are the means ± SE of
three separate experiments and are expressed relativeto the PA
activity of 0 ng /mI PMA.Means without common superscripts are
different (P<0.05).
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Figure 11-7.Effects of dbcAMP, PMA, 6-DMAP and OA on germinal
vesicle breakdown (GVBD) and development to metaphase II (M II).
Porcine oocyte-cumulus cell complexes were cultured in control
(C), 1% DMSO (DMSO), 100 ng/ml PMA (PMA), 2.5 mM dbcAMP (cAMP),
2 mM 6-DMAP (6-DMAP) and 25 nM OA (OA).Percentages without
common superscripts for GVBD or M II are different (P<0.05).
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Figure 11-8. Effects of 6-DMAPon PA activities inin vitro matured
POCC. Results are themeans ± SE of three separate experiments
and are expressed relative to the PAactivity of 0 mM 6-DMAP.
Means without common superscriptsare different (P<0.05).
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Figure 11-9. Zymographic analysis of in vitro matured POCC
cultured in 0 (lane 1), 2.5 (lane 2), 7.5 (lane 3), 25 (lane 4), 75
(lane 5) and 250 nM OA (lane 6).Lane 7 contains 0.1 1U/m1 human
urokinase.
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Figure 11-10. Zymographic analysis of in vitro matured POCC
cultured in 25 (lanes 3 and 7) and 0 nM OA (lanes 4 and 8).Lanes 1
and 5 contain 5 ng/ml human tPA and lanes 2 and 6 contain 0.1
IU/m1 human urokinase.Lanes 1, 2, 3 and 4 are in the zymograph
with 10 mM amiloride, and lanes 5, 6, 7 and 8 are in the zymograph
with 0 mM amiloride.
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Figure 11-11.Effects of OA on PA activities inin vitro matured
POCC. Results are the means ± SE of three separate experiments.
Tissue type PA and tPA-PAI complex activities are expressed
relative to the PA activity of 0 nM OA, and uPA activities are
expressed relative to the PA activity of 25 nM OA.Means without
common superscripts are different (P<0.05).
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PARTIAL CHARACTERIZATION AND EVALUATION OF THE EFFECTS
OF METABOLIC INHIBITORS ON PLASMINOGEN ACTIVATORS
PRODUCED BY BOVINE OOCYTE- CUMULUS CELL COMPLEXES
MATURED IN VITRO.98
Abstract
Plasminogen activators (PA) were partially charaterized by
immunoprecipitation and the effects of cycloheximide, actinomycin
D and tunicamycin on PA actitvity and maturation rate in bovine
oocyte-cumulus cell complexes (BOCC) matured in vitro were
determined.Cumulus cell-enclosed oocytes were collected from 2
-5 mm antral follicles and cultured in TCM 199 with 0.3%
polyvinylpyrrolidone for 24 h.Plasminogen activator activityin
BOCC was measured using SDS-PAGE, casein agar zymography and
densitometery.Three plasminogen-dependent protease activities
(92-95 kD, 71-73 kD and 49-51 kD) and one PA inhibitor (PAI, 52
kD) were observed in matured BOCC.Immunoprecipitation
experiments suggested that the 49-51 kD band is a urokinase-type
PA, the 71-73 and 92-95 PA (tPA) and
tPA-PAI complex, respectively, and the PAI (52 kD) isPAI-1.
Changes in PA activity due to the various treatments were
expressed relative to the PA activity in 20 BOCC.In BOCC cultured
in1 and 10 µg /ml cycloheximide or 5 and 50 11M actinomycin D, PA
activity decreased (P<0.05) and germinal vesicle breakdown and
maturation rate were inhibited.Incubation of BOCC with 0.5 p.g/m1
tunicamycin reduced the molecular mass of tPA, tPA-PAI complex
and PAI-1 by 5-10%, however PA activity was not inhibited by
tunicamycin.These data suggest that BOCC matured in vitro
produce uPA, tPA and PAI-1; the latter which complexes with tPA
to form a high molecular mass species.Both mRNA and protein
synthesis are necessary for PA production and germinal vesicle99
breakdown in BOCC matured in vitro, however inhibition of
glycosylation does not affect PA activity.
Introduction
The plasminogen activator (PA) system provides an important
source ofextracellular proteolysis accompanying cell migration
and tissue remodelling (Dano et al., 1985).Two principal PA have
been identified, tissue-type (tPA) and urokinase-type PA (uPA), and
their activities are modulated physiologically by several different
inhibitors including PA inhibitors-1(PAI-1), -2 (PAI-2) and -3
(PAI-3) (Dano et al., 1985; Kruithof, 1988).The role of PA in
ovulation has been suggested based on the observation that PA
activityin the ovary is markedly increased in granulosa cells
obtained from follicles shortly before ovulation (Beers et al.,
1975).It has also been demonstrated that meiotic maturation of
oocytes is associated with increased levels of tPA activity. In
rats and mice, granulosa and cumulus cells secrete both tPA and
uPA, however oocytes denuded of cumulus cells produce only tPA
during spontaneous in vitro maturation (Huarte et al., 1985; Liu et
al.,1986)
Most mammalian oocytes resume meiotic maturation when they
are released from the follicle. The regulatory mechanisms
involved inmeiotic maturation are quite different among species.
In mice and rats, germinal vesicle breakdown (GVBD)occurs
independently of protein synthesis (Schultz and Wassarman, 1977;
Clarke and Masui, 1983), however both protein synthesis and
transcription are required for GVBD in cattle (Hunter and Moor,100
1987; Kastrop et al., 1991).Actinomycin D, a specific
transcriptionalinhibitor, and cycloheximide, a blocker of protein
synthesis, reduced PA activityinrat granulosa cells (Knecht,
1986) and osteoblasts (Hamilton et al., 1985).Although
transcription and protein synthesis are required for the full
expression of PA in rat granulosa cells, this has not been
determined in oocyte-cumulus cell complexes from cattle.Tissue
type PA, uPA and PA inhibitors are glycoproteins (Ranby et al.,
1982; Hart and Rehemtulla, 1988).Tissue type PA is
approximately 7% glycosylated (Dano et al., 1985).The degree of
glycosylation and the effects of inhibiting glycosylation on PA
activity in bovine oocyte-cumulus cell complexes (BOCC) also have
not been determined.In a previous report, our laboratory
demonstrated that on the basis of molecular mass, BOCC produced
tPA, uPA and PAI.The identity of the PAI, however, was not
definitivelydetermined.
Therefore, the objective of this study was to investigate the
effects of cycloheximide, actinomycin D andtunicamycin on PA
activity and maturation rate and characterize the type of PA and
PAI produced in BOCC matured in vitro.
Material and Methods
Recovery and culture of BOCC
Cattle ovaries were collected from a local slaughter house and
transported to the laboratory in physiological saline (25-30 C)
within 4 h.Oocytes were aspirated from 2- to 5-mm follicles and
washed with Tissue Culture Medium 199 (TCM 199, Sigma Chemical101
Co., St. Louis, MO, USA) supplemented with polyvinylpyrrolidone
(PVP, 3 mg/ml, Sigma), sodium pyruvate (50 1.1g/m1), sodium
bicarbonate (2.6 mg/ml) and 10 mI /Iof an antibiotic antimycotic
solution (Sigma).Oocytes were pooled and carefully selected
under a stereomicroscope and only those with compact cumulus
cells were cultured in TCM199 modified as above at 39 C in a
humidified 5% CO2 in air atmosphere (Saeki et al., 1990).Twenty
oocytes were cultured for each treatment.Cycloheximide (Sigma)
and actinomycin D (Sigma) were diluted with TCM 199. Tunicamycin
was diluted from a 5 mg/ml stock solution dissolved in
dimethylsulfoxide (DMSO, Sigma).
Electrophoresis and Zymography
Electrophoresis and zymography were performed using the
procedures described by Dyk and Menino (1991) which were
modified from Granelli-Piperno and Reich (1978) and Vassal liet al.
(1984).Twenty oocytes with evenly enclosed cumulus cells were
combined with 90 III of sample buffer ( 5% SDS; 20% glycerol;
0.0025% bromophenol blue in 0.125 M Tris HCI buffer).One
hundred microliters of BOCC samples were pipetted into
castellated wells in a 4% stacking gel with a 12% separating gel.
Electrophoresis was conducted at 20 mA through the stacking gel
and 30 mA through the separating gel for 2 to 4 h.Zymographs
were prepared by dissolving 4 g of nonfat dry milk (Carnation Co.,
Los Angeles, CA, USA) in 100 ml of buffer containing 0.0013 M
CaC12.2H20, 0.1 M glycine, 0.038 M Tris and 0.05 M Na azide. Seven
milliliters of the nonfat dry milk mixture were heated to 55 C and102
combined with 7.0 ml of 2% melted agarose (Sigma) with distilled
water also maintained at 55 C.Purified human plasminogen was
added to the warmed mixture of 4% nonfat dry milk and 2%agarose
to yield a final concentration of 25-30 µg /ml and 10 ml of this
mixture was casted onto a warmed 13X6 cm glass plate.
Zymographs containing 0 .1g/m1 plasminogen were also used for
detection of any nonspecific proteolytic activity.
Reverse zymographs were prepared according to Erickson et al.
(1984).Briefly, zymographs were prepared as regular zymographs
except 500 ul of purified 5 IU/m1 urokinase (American Diagnostica,
Inc.) was added.The gel sandwich (acrylamide gel and casein-agar
gel) was incubated at 39 C for 3-5 h until lysis occurred.
Immunoprecipitation
For the immunoprecipitation, 150 BOCC in SDS solubilization
buffer (Huarte et al., 1985) were used at a final volume of 100 pl.
Solubilized BOCC were divided among six treatments.Treatments
consisted of the addition of 30 ul of PBS, 5 mg/ml non-specific
goat immunoglobins (NSIgG, Sigma) or goat antibodies to human
tPA (anti-tPA), uPA (anti-uPA), PAI-1(anti-PAI-1) or PAI-2 (anti-
PAI-2) (American Diagnostica Inc., Greenwich, CT, USA) and
incubated overnight at 4 C.Thirty µl of protein G-bearing
Streptococcus cells (Cal-Biochem; La Jolla, CA)were added to each
sample and incubated for 2.5 h with shaking atroom temperature.
Samples were centrifuged with a Beckman microfuge and the
supernatants were recovered.The pellets were rinsed three times
with PBS by vortexing and centrifugation.Supernatants and pellets103
were combined with SDS sample buffer and evaluated for PA using
SDS-PAGE and zymography.Lytic zones (PA activity) and dark
zones (PAI activity)in the zymograph were quantified
densitometrically and were expressed relativeto the PBS
treatment.
Assessment of In Vitro Maturation
At the termination of culture, thirty to fifty BOCC from each
treatment were fixed and stained for assessment of meiotic stage.
Cumulus cells were first removed from oocytes by vigorous
votexing.The denuded oocytes were washed twice in 2.0% sodium
citrate, transferred to 0.7% sodium citrate for 3 min, fixed onto
microscope slides with 25% acetic acid in ethanol, air dried
(McGaughey and Chang, 1969) and stained with hematoxylin and
eosin.Oocytes were evaluated for meiotic stage using bright-field
microscopy.
Data Analysis
All experiments measuring PA activity were repeated at least
three times.Protease activity was quantified by densitometric
scanning of the zymograph using the Model 1650
reflectance/transmittance scanning densitometer (Bio-Rad) and
computing software (Hoefer Scientific Instruments, San Francisco,
CA, USA).A polar planimeter ( Model L -20 -M; Lasico, Los Angeles,
CA, USA) was used to trace the densitometric scans and determine
the lytic areas.Differences in PA activities in each experiment
were determined by analysis of variance and Fisher's least
significant difference procedures.Differences in oocyte
maturation rates were determined using Chi-square procedures.104
All analysis were conducted using the NCSS statistical software
program (Number Cruncher Statistical System 4.01, 1984, Hintze,
JL, Kaysville, UT; USA).
Results
Zymographic analysis of BOCC matured in vitro revealed the
presence of three plasminogen dependent lytic zones (92-95 kD, 71
73 kD and 49-51 kD) and one PA inhibitor (PAI) activity (52 kD,
Figure III-1).As shown in Figure III-2,anti-uPA and anti-tPA
precipitated the 49-51 kD and 71-73 kD molecular mass species,
repectively, suggesting the 49-51 kD band is uPA and the 71-73 kD
band is tPA.When samples were treated with anti-tPA and anti-
PAI-1, the high molecular mass species 92-95 kD was precipitated
ineither treatment, however neither anti-uPA nor anti-PAI-2
reduced this activity (Figure111-2).Plasminogen activator
inhibitor activity was highinthe pellet following treatment with
anti-PAI-1 whereas no activity was observed in the pellet after
treatment with anti-PAI-2, suggesting the PAIisPAI-1(FigureIII-
3).In BOCC cultured with 1 and 10 ug/ml cycloheximide and 5 and
50 1AM actinomycin D, all three forms of PA decreased (P<0.05,
Figures III-4, 5 and 6).Oocyte maturation rate was also inhibited
(P<0.01; Figure III-7).As shown in Figure III-8, when BOCC were
treated with 0.5 and 5 µg /ml tunicamycin, the molecularmass of
tPA, tPA-PAI complex and PAI-1were reduced by 5-10%, whereas
the molecular mass of uPA did not change. The reduced molecular
masses of tPA and tPA-PAI complex following treatment with the105
glycosylation inhibitor were 64-67 and 86-89 kD, respectively, and
the reduced form of PAI-1is 48-49 kD. Total PA activity was not
inhibited by tunicamycin (Figure III-9), however both GVBD and
oocyte maturation rate were reduced (Figure III-7).
Discussion
Zymographic analysis revealed that in vitro matured BOCC
produced three plasminogen dependent proteases (49-51, 71-73
and 92-95 kD) and one PAI (52 kD) during in vitro maturation.The
49-51 kD species is likely uPA because antiserum to human
urokinase successfully precipitated this activity.The molecular
mass of the 49-51 kD species also corresponds to the values (31-
55 kD) reported by Dano et al. (1985) for uPA.Treatment with ant
tPA reduced both the 71-73 and 92-95 kD forms in the supernatant
and increased activities in the pellets whereas anti-huPA had
littleeffect.Treatment with anti-PAI-1reduced both the 71-73
and 92-95 kD activities and PAI activity in the supernatant and
increased activities in the pellet suggest that BOCC matured in
vitro produce uPA, tPA and PAI-1; the latter which complexes with
tPA to form a high molecular mass species.Tissue-type PA is
synthesized as a proenzyme with a molecular mass of
approximately 70 kD and composed of two polypeptide chains, a
heavy chain (40 kD) and light chain (30 kD), linked by a single
disulfide bond (Dano et al., 1985; Degen et al., 1986).Plasminogen
activator inhibitors are a family of specific inhibitors of PA.The
PAI can form complexes with either uPA or tPA that are resistant
to breakdown by SDS and PA-PAI complexes retainzymographic106
activity (Hart and Rehemtulla, 1988; Andreasen et al., 1990).
Typically complexes between serine proteases and serine protease
inhibitors (serpins) are of lower molecular mass than would be
mathmatically expected, due to release of a cleavage fragment
upon association (Wilman and Co lien, 1979; Bartlett and Menino,
1993).Our study showed that the PAI produced by BOCC matured in
vitro is a PAI-1.At least three classes of PAI have been identified
on the basis of immunochemical reactivity and recombinant DNA
probes (Hart and Rehemtulla, 1988).Plasminogen activator
inhibitor-1is a 52 kD glycoprotein which is synthesized by
endothelial cells, hepatocytes and platelets, and is present in
plasma.Plasminogen activator inhibitor-1inhibits tPA, as well as
uPA, by forming SDS-stable complexes.Plasminogen activator-2
is synthesized by various tissues including the placenta and
macrophages.Unlike PAI-1, PAI-2 exists in two different forms.
Intracellularly, PAI-2 exists as a nonglycosylated molecule with a
molecular mass of 47 kD, whereas the secreted form is
glycosylated and has a molecular mass of 60 kD.Plasminogen
activator inhibitor-2is more selective inhibitor of uPA whereas
PAI-1 has a higher binding affinity for tPA.Plasminogen activator
inhibitor-3 is predominately found in urine and plasma and has a
molecular mass of 51 kD.Plasminogen activator inhibitor-3 has
recently been reported to be identical to the inhibitor of activated
protein C.
Actinomycin D, a blocker of mRNA synthesis, and cycloheximide,
a protein synthesis inhibitor, reduced PA production in BOCC.The
present study demonstrated that both transcriptional and107
translational activityare critical duringinvitro maturationin
BOCC for GVBD and for PA production.Total RNA and poly (A)-
containing mRNA have been shown to accumulate during the growth
of primary mouse oocytes (Bachvarova, 1985).Interestingly, the
quantity of tPA mRNA remained constant in fully grown primary
mouse oocytes cultured under conditions that prevented resumption
of meiosis (Huarte et al., 1987).Huarte et al. (1987) reported that
inhibition of RNA synthesis by actinomycin D or a-amanitin did not
affect accumulation of tPA during maturation.In contrast, culture
in the presence of protein synthesis inhibitors completely
prevented enzyme production.During meiotic maturation in
mammals, many intracellular changes occur related to the pattern
of protein synthesis (Moor and Crosby, 1986; Kastrop et al., 1990;
Gal et al., 1992).Protein synthesis plays an important role in the
control of meiotic division.In large animals, including swine and
cattle, resumption of meiosis requires active protein synthesis for
GVBD (Fulka et al., 1986; Hunter and Moor, 1987), however in
rodents, GVBD occurs independently of protein synthesis (Shultz
and Wassarman, 1977; Fulka et al., 1986).Kastrop et al. (1991)
have also reported that both mRNA and protein synthesisare
necessary for GVBD and further development to metaphase II.
Tissue-type plasminogen activator is a glycoprotein with
approximately 7% carbohydrate (Randy et al., 1982; Kruithof et al.,
1988).Little et al. (1984) reported that the carbohydrate moeity
dose not change enzyme activity because removal of the
carbohydrate by glycosidase did not alter enzyme activity.108
However glycosylation of tPA plays an integral role in transport of
the protein out of the cell.Tunicamycin inhibits glycosylation of
asparginyl residues during glycoprotein synthesis (Waecheter and
Lennerz, 1976; Rothman et al., 1978).Our results showed that
incubation BOCC with tunicamycin reduced the molecular mass of
tPA, tPA-PAI complex and PAI by 5-10%, however PA activities
were not changed by tunicamycin.
In conclusion, BOCC matured in vitro produce uPA and tPA and PAI.
1that complexes with tPA to form a high molecular mass species.
Both mRNA and protein synthesis are necessary for PA production
and germinal vesicle breakdown in BOCC matured in vitro, however
inhibition of glycosylation does not affect PA activity.109
Figure III-1. Zymographic (lane 1) and reverse zymographic (lane 2)
analysis of in vitro matured BOCC.
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Figure 111-2.Relative PA activities in the A) supernatant and B)
pellet fractions of immunoprecipitated BOCC matured invitro.
Results are the means ± SE of three separate experiments andare
expressed relative to the PA activity of the PBS treatment.
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Figure III-3. Zymographic analysis of plasminogen activator
inhibitor (A), anti-human PAI-1; lanes1& 4, anti-human PAI-2;
lane 2 & 5, NSIgG; lane3 & 6,and relative activities (B) in
immunoprecipitated BOCC matured in vitro.Results are the means
± SE of three separate experiments and are expressed relative to
the PA activity of the PBS treatment. Means withoutcommon
superscripts are different (P<0.05).
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Figure III-4. Zymographic analysis of in vitro matured BOCC
cultured in0 (lane 1),1(lane 2) or 10 µg /ml (lane 3)
cycloheximide or 5 ialvi actinomycinD (lane 4).Lanes 5 and 6
contain 0.1IU/m1 urokinase and 5 ng/ml human tPA, respectively.
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Figure 111-5.Effects of cycloheximide on PA activitiesininvitro
matured BOCC. Results are the means ± SE of three separate
experiments and are expressed relative to the PA activity of BOCC
in 0 tg /ml cycloheximide.Means without common superscripts are
different (P<0.05).
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Figure 111-6.Effects of actinomycin D on PA activities inin vitro
matured BOCC. Results are the means ± SE of three separate
experiments and are expressed relative to the PA activity of BOCC
in 0 Wv1 actinomycin D.Means without common superscripts are
different (P<0.05).
1.5
1.0
0.5
0.0
a
II0 ug/ml
5 ug/ml
Ei 50 ug/ml
a a
tPA-PAI tPA uPA11 5
Figure III-7.Effects of cycloheximide, actinomycin D and
tunicamycin on germinal vesicle breakdown (GVBD) and
development to metaphase II (M II).Bovine oocyte-cumulus cell
complexes were cultured in 0 (C) or 11.1.g/m1 cycloheximide (CHX), 5
actinomycin D, and 0.5 and 5 4g/m1 tunicamycin (0.5 Tu and 5
Tu, respectively).Percentages without common superscripts for
GVBD or M II are different (P<0.05).
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b
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Figure Zymographic analysis of in vitro matured BOCC
cultured in 0 (lane 1) or 1% DMSO (lane 2) and 0.5 (lane 3) or 5
µg/m1 (lane 4) tunicamycin.
1 234KD
-97
66
-431 1 7
Figure III-9.Effects of tunicamycin on PA activities inin vitro
matured BOCC. Results are themeans ± SE of three separate
experiments and are expressed relative to the PA activityof BOCC
in 0µg /ml tunicamycin.Means without common superscriptsare
different (P<0.05).
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SUMMARY
This study revealed that in vitro matured bovine oocyte-cumulus
cell complexes (BOCC) produced uPA, tPA and PAI-1 whereas
porcine oocyte-cumulus cell complexes (POCC) produce only tPA
and PALPlasminogen activator activity in either BOCC or POCC
increased in a dose-dependent fashion during in vitro maturation.
Significant PA induction by either BOCC and POCC occurred shortly
after germinal vesicle breakdown, suggesting PA may be
associated with the process of oocyte maturation.Stimulators of
the protein kinase A system increased PA activity in both BOCC and
POCC in dose-dependent fashion.In BOCC cultured with activator
of phospholipid-dependent protein kinase C, total PA activity
increased, however high concentrations of PMA (10 and 100 ng/ml)
decreased tPA activity in matured POCC.Inhibition of
intracellular phosphorylation, transcription and translation
decreased PA activity and inhibited oocyte maturation.Increasing
intracellular phosphorylation using an inhibitor of phosphatase 1
and 2A caused induction and selective enhancement of uPA in POCC
and uPA and PAI-1 in BOCC.Inhibition of glycosylation using
tunicamycin reduced the molecular masses of tPA and PAI-1 by 5-
10%, however PA activities were not changed.122
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EFFECTS OF EXTRACELLULAR POTASSIUM CONCENTRATION ON
BLASTOCOEL FORMATION AND EXPANSION AND HATCHING IN PORCINE
EMBRYOS DEVELOPING IN VITRO.
Abstract
Effects of varying the potassium concentration on blastocoel
formation and expansion and hatching in porcine embryos were
determined.One hundred seventeen porcine embryos were cultured
individuallyin 50-41 microdrops of glucose-free Whitten's medium
containing .4% BSA under paraffin oilin a humidified atmosphere
of 5% CO2 in air at 39 C.Two-cell to early blastocyst stage
embryos were randomly allocated to medium containing 1.5, 3, 6
and 12 mM potassium.Osmolarity was maintained by adjusting the
NaCI concentration.Overall embryo diameter (OD), blastocoel
diameters (BD),if present, and zona pellucida thicknesses (ZPT)
were measured every 24 h with an ocular micrometer.Incidences
of blastocoel formation and expansion from two to four-cell
embryos were not different (P>.05) in medium with 1.5, 3, 6 or 12
mM potassium.More two to four-cell embryos commenced hatching
in 3 mM potassium (44%) than 1.5 mM (11%) (P<.05) and 12 mM
(16%) potassium (P<.10).Percentages of morulae to early
blastocysts undergoing blastocoel expansion and hatchingwere not
different (P>.05) among the four treatments.Onset of blastocoel
formation by cultured four-cell embryos was not different (P>.05)
among 1.5, 3, 6 and 12 mM potassium concentration, however
expansion was delayed (P<.05) in 1.5 mM (104 ± 5.7 h) compared to138
6 mM (84 ± 6.0 h) and 12 mM (82.9 ± 5.2 h) potassium. No
differences (P>.05) due to potassium concentration were observed
in OD, BD and ZPT attained by either two to four-cell embryos or
morulae to early blastocysts.These results suggest that a low
concentration of potassium (1.5 mM) in the culture medium delays
blastocoel expansion and reduces hatching.Although the porcine
embryo appears to be relatively tolerant of higher concentrations
of potassium, the potassium requirements at different cell stages
may require further investigation.
Introduction
Blastocoel formation and expansion and hatching are important
processes in early preimplantation embryo development that are
dependent on the transepithelial ion transport properties of the
trophectoderm.Two properties of the trophectoderm are
responsible for generating transcellular ion transport: tight
junctions between adjacent trophectodermal cells and the
presence of the Na/K ATPase on the basolateral cell surfaces
(Benos and Biggers, 1981). Hydrostatic pressure accumulation
due to water influx in the blastocoel in part causes the force
responsible for rupture of the zona pellucida and hatching.
Previous studies in the mouse have shown that embryo
development is sensitive to the concentration of potassium in the
culture medium.Wiley (1984) and Wiley et al. (1986) reported
that reducing potassium (0.6 and 1.4 mM) in the culture medium
accelerated development oftwo to four cell stage embryos and
morulae into blastocysts compared to medium with the common1 3 9
concentration (6 mM) of potassium (Biggers et al., 1971).
Conflicting results have been presented by Roblero and Riffo
(1986) who reported that high potassium (25 mM), similar to that
found in the mouse oviduct, increased cell numbers of morulae and
blastocysts developing from two-cell embryos compared to 4.7 mM.
Studies in mice, swine and humans have reported a high potassium
concentration in oviductal fluid compared to the bloodsteam
(Roblero et al., 1976; Iritani et al., 1974; Borland et al., 1980).
Although culture of early cleavage stage porcine embryos to the
blastocyst stage has been accomplished in simple medium with
BSA or serum, few embryos commence and complete hatching in
vitro (Reed et al., 1992).Porcine embryo development has been
improved in mouse oviduct organ culture (Krisher et al., 1989; Reed
etal.,1992), co-culture with oviductal epithelial cells (White et
al., 1989) and in medium supplemented with oviductal fluid
(Archibong et al., 1989). Differences in development under these
various conditions may be due to ionic imbalances or the absence
of macromolecular components, such as growth factors.Therefore
the purpose of this study was to investigate effects of varying the
potassium concentration on blastocoel formation and expansion and
hatching in porcine embryos.
Materials and Methods
Eleven cycling gilts and sows and eight prepuberal giltswere
used.Cycling gilts and sows were checked daily for estrus and
handmated with boars of proven fertility.Prepuberal gilts were
synchronized and superovulated with pregnant mare's serum1 4 0
gonadotropin (PMSG) and human chorionic gonadotropin (HCG) and
bred artificially 24 and 48 h after HCG with commercial semen
(Baker and Coggins, 1968).Prepuberal gilts displaying estrus after
hormone treatment were also hand-mated.Reproductive tracts
were recovered at slaughter and oviducts and uteri were flushed
with glucose-free Whitten's medium (WM) lacking BSA (Whitten
and Biggers, 1968).Flushings were collected into embryological
dishes and observed at 10 X with a dissecting microscope for the
presence of embryos.Embryos were transferred to microdrops of
WM with .4% BSA and evaluated formorphology.Embryos were
randomly allocated to medium containing 1.5, 3, 6 and 12 mM
potassium.Osmolarlity was maintained by adjusting the NaCI
concentration.Embryos were cultured individually in 50
microdrops of WM containing .4% BSA under paraffin oil in a
humidified atmosphere of 5% CO2 in air at 39 C.At 24-h interval
embryos were morphologically evaluated at 100-200 X with an
inverted-stage phase-contrast microscope and overall embryo
diameters (OD), blastocoel diameters (BD),if present, and zona
pellucida thicknesses(ZPD) were measured with an ocular
micrometer.
Differences in the percentages of embryos developing to a
particular cell stage due to treatment were determined by Chi-
square procedures.Differences in OD, BD and ZPT due to
concentration of potassium and time in culture were determined
using two-way ANOVA and Duncan's new multiple range test.All
analysis were performed using the NCSS statistical software1 4 1
program (Number Cruncher Statistical System, Version 4.1, 1984,
J.L. Hintze, Kaysville, UT, USA).
Results and Discussion
Seventy-four two- to four-cell embryos and 39 morulae to early
blastocysts were recovered.Sufficient numbers of embryos were
collected to allow allocation of embryos from a single female to
all four treatments.Incidences of blastocoel formation and
expansion from two to four-cell embryos were not different (P>
.05) in medium with 1.5, 3, 6, or 12 mM potassium (Table 1).More
two to four-cell embryos commenced hatching in 3 mM potassium
(44%) than 1.5 mM (11%) (P<.05) and 12 mM (16%) potassium (P<
.10).Fewer embryos commenced hatching in medium with 6 mM
(28%) compared to 3 mM potassium (44%), however this difference
was not significant.Percentages of morulae and early blastocysts
undergoing blastocoel expansion and hatching were not different
(P> .05) among the four treatments (Table 1).
Onset of blastocoel formation by cultured four cell embryos was
not different (P> .05) among 1.5, 3, 6 or 12 mM potassium, however
expansion was delayed (P< .05) in 1.5 mM compared to 6 and 12 mM
potassium (Table 2).Formation and expansion of the blastocoel are
due to passive entry of water caused by Na/K-ATPase
translocation of Na into the blastocoel (Wiley, 1984; Manejwala et
al., 1986).It has been observed in many mammals that in vitro
embryo development is retarded compared within vivo
development.Different elemental and organic compositions or
hormonal and growth factor deficiencies in culture medium,1 4 2
compared with the natural oviductal and uterine environments,
were suggestedas potential causes of this developmental delay
Roblero and Riffo, 1986).Concentrations of potassium in the sow's
oviduct and uterus are 12 and 16 mM, respectively (Iritani et al.,
1974).The importance of this physiologically high potassium
concentration in the oviductal and uterine microenvironments of
the preimplantation embryo is not well understood.Previous work
has suggested that the high potassium concentration influences
sperm motility and sperm-egg fusion (Boldt et al., 1991).Roblero
and Riffo (1986) observed a dose-related increase in the rate of
cleavage of mouse embryos with 4.7, 10 and 25 mM potassium.
Their results suggest that potassium concentrations similar to the
mouse genital tract improved in vitro development.However
embryo have been observed (Wiley,
1984; Wiley et al., 1986).Cavitation was accelerated when
potassium was decreased from 6 to 0.5 mM and was delayed when
potassium was increased from 6 to 25 mM (Wiley, 1984; Wiley et
al., 1986).It has been suggested that decreasing the concentration
of potassium may hyperpolarize the cell due to the difference
between intra-and extracellular potassium concentrations.
Conversely increasing potassium would depolarize the cell (Cohen
et al., 1976; Wiley, 1984).Itis also possible that potassium plays
different roles in porcine embryos depending on developmental
status.In early embryonic development, potassium may exert an
effect only on embryonic cell division, whereas, during the period
of blastocoel formation, potassium may also affect blastocoel
expansion.143
Figures IV-1 and 2 depict changes in OD, BD and ZPT of two-cell
stage embryos to early blastocysts culturedindifferent
concentrations of potassium.Although low potassium delayed
onset of blastocoel expansion, no significant differences were
observed in OD, BD and ZPT (Figures IV-1 and 2). Maximum
expansion of blastocysts by cultured two- to four-cell embryos
was observed on comparative gestational day 7 in medium with 3,
6 and 12 mM potassium, but on day 8 in medium with 1.5 mM
potassium (Figure IV-1).In conclusion, our results suggest that a
low concentration of potassium (1.5 mM) in the culture medium
delayed blastocoel expansion and reduced hatching. Because
superior development was not observed in medium with 6.0 mM
potassium, the common concentration for most culture media, the
potassium requirements for porcine embryos at different cell
stages may require further investigation.TABLE 1.DEVELOPMENT OF PORCINE EMBRYOS IN MEDIUM WITH 1.5, 3.6 OR 12 mM POTASSIUM
Initial cell
stage
Potassium
concentration
n
Number(%) of embryos developing to
Blastocyst Expanded
blastocyst
Hatching
blastocyst
Hatched
blastocyst
Two- to
four-cell 1.5 mM 19 19(100)8 8(42.1)' 2(10.5)b 1(5.3)
3 mM 18 16(88.9)' 11(61.1)' 8(44.4)'
6 mM 18 15(83.3)' 9(50.0)' 5(27.8)83'
12 mM 19 18(94.7)' 11(57.9)' 3(15.8)b
Morula to early
blastocyst 1.5 mM 10 10(100) 9(90)' 5(50)' 2(20)
3 mM 10 10(100) 9(90)' 6(60)' 2(20)
6 mM 9 9(100) 9(100)' 7(77.8)' 2(22.2)
12 mM 10 10(100) 10(100)' 6(60)'
3' Values in the same column fora specific initial cell stage without common superscripts are different (P<.10).145
TABLE 2.TIME(h)TO BLASTOCOEL FORMATION AND EXPANSION AND
ONSETOFHATCHINGFORFOUR-CELLPORCINEEMBRYOS
CULTUREDIN MEDIUM CONTAINING 1.5,3,6OR12 mM
POTASSIUM
Development to the:
Blastocoyst Expanded Hatching
blastocyst blastocyst
Treatmentn X± SE n X± SE n X± SE
1.5 mM 15 73.6 ± 4.7°11104 ± 5.7° 4120 ± 11.9a
3 mM 1568.3 ± 4.7° 896 ± 5.7Lb 6108 ± 11.9°
6 mM 1362.8 ± 4.7° 984 ± 6.0b 4100 ± 9.7°
12 mM 1560.8 ± 4.3° 982.9 ± 5.2b3 96 ± 16.9°
a.bMeans in thesame column without common superscripts are
different (P<.05).1 4 6
Figure IV-1. Changes in A)overall diameters, B) blastocoel diametersand
C) zona pellucida (ZP) thicknessesfor 2- to 4-cell porcine embryos
cultured in 1.5, 3, 6 or 12 mMpotassium.
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Figure IV-2.Changes in A) overall diameters, B) blastocoel diameters and
C) zona pellucida (ZP) thicknesses for morulae and early blastocysts
cultured in 1.5, 3, 6 or 12 mM potassium.
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